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Summary 
The objective of this study was to apply biophysical fluorescence techniques, i.e. 
FCS and FCCS, to quantitatively study protein-protein interactions in live cells. 
Although both methods have been established, a large portion of FCS/FCCS 
work were done in vitro, and the applications of FCS/FCCS on studies of 
biomolecular interactions in live cells are limited. In particular, single wavelength 
fluorescence cross-correlation spectroscopy (SW-FCCS) had not been applied to 
study molecular interactions in live cell systems. In this thesis, we further 
developed SW-FCCS to study protein-protein interactions in vivo. The biological 
systems studied here are two groups of signaling proteins: the ErbB receptor 
family and Cdc42-related signaling complexes.  
 
Chapter 1 first provides a brief review on both biochemical and biophysical 
methods that are applied to detect protein-protein interactions. The primary focus 
of this chapter is the introduction of the biological backgrounds of the systems 
that were studied in this thesis: the physiological functions of ErbB receptors and 
Cdc42 together with its effectors, and their related topics that were studied by 
using FCS/SW-FCCS.  
 
Chapter 2 introduces the theory of FCS and FCCS, together with their relevant 
applications. The focal points in this chapter are the related mathematic models 
that were utilized in the quantification of complex (dimer) percentages of 
interacting proteins and the determination of the equilibrium dissociation 
 vi
constants of binding proteins. The experimental setups of FCS/SW-FCCS are 
introduced in the last section of this chapter.  
 
Chapter 3 introduces the procedures of biological sample preparations, including 
plasmids construction, tissue culture, transfection methods and sample 
preparation for imaging, FCS/FCCS, phosphorylation assays and quantitative 
flow cytometry.  
 
Chapter 4 describes the characterization of the photodynamic properties of three 
commonly-used fluorescent proteins (FPs), EGFP, EYFP and mRFP, by 
performing FCS on cells expressing these proteins and their fusion proteins. The 
results provided the basic information on the mobility, brightness and 
photodynamic characteristics of FPs and fusion FPs. 
 
Chapters 5 and 6 focus on the interactions between ErbB receptors. Chapter 5 
describes the study of the interactions between ErbB receptors before ligand 
stimulation by performing SW-FCCS. The dimer percentages between 
EGFR/EGFR, EGFR/ErbB2, and ErbB2/ErbB2 were determined through 
quantitative data analysis. The results suggest that the majority of ErbB receptors 
preform dimeric structures on the cell surface before ligand binding. Chapter 6 
describes observations of slower diffusion and irregular fluorescence fluctuations 
with high intensity, which indicates aggregates or oligomerization of the receptors 
 vii
after EGF activation. The results of the two chapters shed light on the activation 
mechanism of ErbB receptors.   
 
Chapter 7 describes further applications of SW-FCCS to investigate the 
intracellular interactions between Cdc42 and its effectors. The concentrations of 
bound complexes ( GRc  ) and unbound EGFP- and mRFP-fusion proteins ( Gc  and 
Rc ) were determined by SW-FCCS. The equilibrium dissociation constants DK  
were obtained through plotting G Rc c×  vs. GRc . The DK  values for effectors 
containing different Cdc42 binding domains indicate SW-FCCS may be applied 
to distinguish the binding strength between interacting molecules in vivo.  
 
In conclusion, this thesis reveals SW-FCCS as a novel tool to quantitatively study 
biomolecular interactions in live cells.   
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Chapter 1  
Introduction 
 
Organisms dynamically coordinate their activities in response to 
environmental changes through communication with the environment. Cell 
signaling is part of the communication system (1). The abilities of cells to 
receive and process signals are essential for organisms to regulate their 
actions such as development, tissue repair and immunity. Errors in cell 
signaling pathways may result in vital diseases such as cancers, Alzheimer’s 
disease and cardiovascular diseases (2-7). Thus it is of fundamental 
importance to investigate cellular signaling pathways and abnormal 
activations of signaling proteins, which may help in finding new drug targets. 
Furthermore, the discovery of activation mechanisms of signaling proteins 
may help to design drugs more efficiently.  
 
The discovery of novel cell signaling pathways requires the study of 
interactions between signaling proteins. Traditional biochemical methods and 
genetic screening methods have been widely employed to study protein-
protein interactions (8-12). Recently, biophysical methods have been 
developed as new approaches to detect protein-protein interactions (13-18). 
In this study, two spectroscopic methods, fluorescence correlation 
spectroscopy (FCS) and fluorescence cross-correlation spectroscopy (FCCS), 
have been applied to study the interactions between signaling proteins in vivo. 
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Quantitation of molecular interactions in vivo is one key advantage of the two 
techniques. 
 
Two groups of signaling components have been studied in this thesis, two 
members from the epidermal growth factor receptor (EGFR/ErbB) family and 
a Rho family GTPase Cdc42 (cell division control protein 42 homology) 
together with its effector proteins. ErbB family receptors receive signals upon 
ligand binding and transmit signals into the inside of the cell through activating 
intracellular signaling proteins. Cdc42 is one important node on the 
intracellular signaling network (1, 19). Both ErbB receptors and Cdc42 are 
involved in signaling pathways that regulate cell growth, division and motility 
(20-22).  
 
1.1 Methods to detect protein-protein interactions 
1.1.1 Biochemical methods and library-based methods  
Biochemical techniques to identify protein-protein interactions include cross-
linking, coimmunoprecipitation (co-IP) and copurification by chromatography. 
Chemical cross-linking and co-IP are classical methods and have been most 
commonly employed to detect protein-protein interactions. Cross-linking can 
be accomplished either in vivo by using membrane permeable cross-linking 
reagents or in vitro by using labeled photoactivatable cross-linkers (23, 24). 
One important advantage of cross-linking is that it strengthens weak 
interactions that otherwise may be destroyed during protein handling 
processes such as detergent solubilization. As a matter of fact, the 
interactions between EGF receptors that we studied in this thesis, have been 
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studied by using cross-linking and followed by sucrose density-gradient 
centrifugation (25). There are several disadvantages of biochemical methods 
to identify protein-protein interactions. First, biochemical methods are time-
consuming as they normally require large amounts of protein purification work. 
Second, they require specific reagents, such as cross-linkers and antibodies 
that bind to target proteins. In addition, many optimization steps in protein 
handling need to be conducted before the final detection of interacting 
complexes.    
 
Library-based methods were developed to screen large libraries of genes and 
gene fragments whose products may interact with a protein of interest. Phage 
display and yeast two-hybrid (Y2H) are two typical library-based screening 
methods. Y2H is a genetic method that uses activities of transcriptional 
activators to measure protein-protein interactions (26, 27). This method is 
based on the fact that the DNA-binding domain and activation domain of the 
activator need not to be covalently linked and can be brought together by any 
two interacting proteins to activate gene transcription. The significance of Y2H 
is that it can be applied to screen libraries of activation domain hybrids to 
identify numerous proteins that bind to a protein of interest, and result in the 
availability of the cloned genes encoding identified binding proteins. The 
major limitation of Y2H is that target proteins must be able to be localized in 
the nucleus since interaction between bait and prey occurs in the nucleus. In 
addition, the high-throughput of Y2H also faces the problem of a high ratio of 
false positives arising from self-activation (9, 11, 28). Thus biochemical 
methods or other approaches need to be performed to confirm the 
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interactions observed by Y2H. This is feasible since the cloned genes of 
interacting proteins are obtained after Y2H screen.  
 
1.1.2 FCS, FCCS and other biophysical approaches 
FCS was originally introduced to monitor a chemical reaction at equilibrium, 
i.e. ethidium bromide binding to DNA (29). The technique is based on the 
thermodynamic fluctuations of fluorescent particles, that is, it measures 
temporal fluorescence fluctuations which originate from particles diffusing in 
and out of a small observation volume. Except for diffusion of fluorescent 
particles, some other factors also cause fluorescence fluctuations, such as 
photophysical processes or photochemical reactions of the fluorophores. 
Consequently, several valuable parameters can be obtained from statistic 
analysis of the temporal fluorescence fluctuations, such as the average 
number of fluorescent particles in the observation volume, the average 
residential time of fluorescent particles in the observation volume (namely the 
diffusion time) and characteristic time of the photodynamic processes of 
fluorophores. Binding of a small fluorescence-labeled biomolecule to a relative 
large non-labeled molecule results in an increase of the diffusion time (30). 
Thus FCS can be applied to study molecular interactions through monitoring 
diffusion rates of fluorescence labeled probes. For instance, FCS has been 
used to investigate the dissociation kinetics of rhodamine-labeled EGF (Rh-
EGF) binding to EGF receptors (31).  
 
If the difference in mass between two interacting molecules is not significant 
enough to affect the diffusion constant, cross-correlation analysis can be 
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applied to improve the detection sensitivity. The concept of dual-color 
fluorescence cross-correlation analysis was suggested by M. Eigen and R. 
Rigler (32), and the first experimental setup was reported by P. Schwille et al 
(33). The basic idea of applying FCCS to study molecular interactions is that 
when two molecules interact with each other and form a complex, the two 
different fluorescence labels should show the same fluorescence fluctuation 
traces in the two detection channels when the complex passes through the 
observation volume. From the analysis of autocorrelation functions (ACF) in 
each channel and cross-correlation functions (CCF) between the two 
detection channels, it is possible to calculate the concentrations of bound and 
unbound species in the reaction system (34). Therefore, the percentages of 
interacting complexes can be obtained and the dissociation constant DK  at 
equilibrium can be obtained. A more detailed introduction of FCS/FCCS 
theory and applications will be given in Chapter 2, and the data analysis 
results will be introduced in subsequent chapters, respectively.  
 
Other fluorescence techniques have also been applied to study protein-
protein interactions (16, 35-39). Förster resonance energy transfer (FRET) is 
one of the techniques that have been widely applied to study biomolecular 
interactions in vivo. The idea of applying FRET to monitor molecular 
interactions is that when two molecules interact with each other, the two 
fluorescence labels may be brought close enough to allow direct dipole-dipole 
coupling and a non-radiative transfer of energy from the fluorophore at its 
excited electronic state (the donor) to the nearby fluorophore (the acceptor) 
(39). Through observation of the energy transfer one can estimate the 
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interactions of the two labeled molecules. FRET measurements can be done 
through donor or acceptor photobleaching, fluorescence lifetime imaging 
(FLIM), or through monitoring sensitized emission. For the interactions 
between the signaling proteins we studied here, our collaborators also applied 
FRET to investigate the interactions.  
 
One key advantage of FCS and FCCS is that the two methods can 
quantitatively determine interactions. Imaging techniques, such as fluorescent 
protein fragment complementation methods (40) and proximity ligation (36),  
can only qualitatively show interactions by imaging fluorescence in cells. 
Bioluminescence resonance energy transfer (BRET) and FRET are also 
limited by the distance between two fluorescent labels, i.e. two labels must be 
close enough to form fluorophores (for complementary methods) or to transfer 
energy from donor to acceptor (for FRET distance <100 Å). FCS and FCCS 
are not limited by distance between two fluorescent labeled particles. Most 
importantly, autocorrelation analysis accurately determines the local 
concentrations of fluorescence labeled particles (32), and cross-correlation 
analysis determines the concentration of binding complexes (33). As 
mentioned before, from these concentrations it is possible to calculate the 
complex percentages and to obtain the dissociation constant DK . In this study, 
we focused on the quantitative analysis of the interactions between signaling 
proteins through FCS/FCCS measurements. 
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1.2 Cell signal input by ErbB receptor tyrosine kinases 
1.2.1 Signal initiation: activation of the ErbB receptor tyrosine 
kinases 
ErbB receptors mediate signal transduction events which regulate cell 
proliferation, differentiation and apoptosis (20). The ErbB family consists of 
four members, EGFR/ErbB1, ErbB2/HER2/Neu, ErbB3 and ErbB4, which are 
all composed of three domains, an extracellular domain, a transmembrane 
domain and a cytoplasmic kinase domain. The four ErbB receptors share two 
homologous Cys-rich domains in their extracellular region, CR1 and CR2. 
Numerous ligands with a conserved EGF-like domain bind to ErbB1, such as 
EGF, transforming growth factor (TGF)-α, heparin-binding epidermal growth 
factor (HB-EGF) (41). Neuregulins (NRGs) bind to ErbB3 and ErbB4, but no 
ligand has been identified to bind to ErbB2.  
 
Generally, two ligands bind to the extracellular domains of two receptor 
subunits and form a 2:2 complex (42), resulting in activation of the intracellular 
kinases of the receptors. Upon ligand binding, the activated kinase then 
phosphorylates the tyrosine residues at the carboxyl-terminus (C-terminus) 
domain of the partner receptor subunit, which is called 
transautophosphorylation. This phosphorylation results in conformational 
changes of the C-terminus domain of the receptor, so that intracellular 
adaptor proteins or other enzymes can bind to the phosphorylated sites of the 
receptor. These intracellular signaling proteins then trigger a number of 
downstream signaling pathways (43, 44). For instance, phosphorylation of the 
tyrosine residues of EGFR results in conformational change of its C-terminus 
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domain, to expose binding sites for Src-homology-2 (SH2) domain-containing 
proteins and phosphotyrosine-binding (PTB) domain-containing proteins. 
Adaptor proteins with a SH2-binding domain such as Grb2 (growth factor 
receptor-bound protein 2) bind to the phosphorylated tyrosine residues, and 
bring the guanine nucleotide exchange factor (GEF) SOS (Son of Sevenless) 
to the activated receptors. The receptor-bound SOS promotes the removal of 
guanosine diphosphate (GDP) from Ras, so that Ras can bind to guanosine 
triphosphate (GTP) and become active. This initiates the Ras-activated 
mitogen-activated protein kinase (MAPK) cascade (45). The final targets on 
the signal transduction pathways are transcription factors, such as Sp1 
(transcription factor Sp1), Myc (transcription factor p64) and Stat (signal 
transducer and transcription activator) (41). After activation, these 
transcription factors translocate to the nucleus and bind to DNA to activate 
gene transcription, resulting in cell growth and division.  
 
1.2.2 Activation mechanisms of the ErbB receptors  
Two EGFs bind to two receptor subunits to form a 2:2 complex for the 
activation of the kinase domain. Prior to ligand binding, however, it remains 
controversial whether the receptor has a monomeric or dimeric structure. 
Different models have been proposed for the activation mechanism of the 
ErbB receptors (25, 46, 47). One possibility is that the receptor exists in a 
monomeric form on native membranes, and ligand binding induces receptor 
dimerization to form the 2:2 complex. This dimerization can be either 
mediated primarily by interactions between the two ligands, or by the two 
receptors. The “Ligand-mediated dimerization” mechanism assumes that 
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receptor dimerization is mainly mediated by the two EGFs. The two ligands 
may interact with each other to form a dimer and then induce receptor 
dimerization, or each EGF “covalently” interacts with two receptors (48, 49). 
“Receptor-mediated dimerization” assumes that EGF binding induces a 
conformational change of the receptor so as to expose its dimerization 
surface (48). Another possibility is that before ligand binding, the receptors 
may already form dimeric structures on the plasma membrane (25, 50-53). 
The preformed dimers may stay inactive on native membranes, and the 
dimeric structure changes to an active form after ligand stimulation to initiate 
signal transduction (25).  
 
As shown by the crystal structure of EGF with the extracellular domain of 
ErbB1 (42), there is no direct interaction between the two ligands, and each 
ligand interacts with only one receptor. So the “ligand-mediated” dimerization 
mechanism is not the activation mechanism for the ErbB family receptors. The 
dimeric structure of the 2:2 complex should be mainly mediated by the 
interactions between the two receptor subunits. However, it remains unknown 
whether the interactions between the two receptors occur only after ligand 
stimulation, or the two receptors interact with each other before ligand binding. 
In the former situation the receptors exist as monomers on the cytoplasmic 
membrane, and ligand binding induces two receptors to interact with each 
other and form a dimeric structure. This is called the “dimerization model”. 
While in the latter situation, the receptors interact with each other to form 
dimeric structures before ligand stimulation. Such dimeric structures may be 
inactive, and ligand binding induces conformational changes of the receptor 
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dimers so that the dimers change to their active form. For example, the 
“rotation/twist model”, proposed by Moriki et al., predicts that EGFR preforms 
dimeric structures on cell membranes, and ligand binding induces rotation of 
the receptor transmembrane domains, resulting in dissociation of the 
cytoplasmic kinase dimers (25). The dissociation makes the kinase domain 
accessible for its substrates for phosphorylation. In summary, the major 
controversy between the models is whether ErbB receptors exist in 
monomeric or dimeric structures on membranes before ligand binding. Fig 1.1 
shows the “dimerization model” and “rotation/twist model” that were proposed 
for the activation mechanism of ErbB receptors. Thus by studying the ternary 
structure of the ErbB receptors on native cell membranes, we may be able to 
tell when the interactions between the two receptors happen, and discover the 
activation mechanism.   
 
It is difficult to determine the ternary structure of the ErbB receptors through 
conventional methods such as crystallization. First, it is technically difficult to 
grow crystals of full-length membrane proteins (54). Besides, the very flexible 
C-terminus of the ErbB receptor makes it even more difficult to obtain a stable 
crystal structure. Other methods such as chemical cross-linking and co-IP can 
also be used to detect dimers of the cell-surface receptors, however, all the 
chemical cross-linkers are too unstable in aqueous buffer to quantitatively trap 
the dimers (25, 55). Since the dimeric structure might also be unstable against 
detergent solubilization (25), the structural analysis should be conducted in 
vivo on the surface of live cells. In the present study, therefore, we mainly 
applied two fluorescence techniques, i.e. fluorescence correlation 
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spectroscopy (FCS) and single-wavelength excitation fluorescence cross-
correlation spectroscopy (SW-FCCS), to study if homo- and heterodimeric 
structures of ErbB1 and ErbB2 exist on cell membranes before ligand 
stimulation. By examining the receptor’s ternary structure on the live cell 
surface, we may be able to discover the activation mechanism of the ErbB 
receptors.  
 
 
Fig. 1.1 Activation models of ErbB receptors. (A) “Dimerization model”, ErbB 
receptors exist in monomeric form on native membranes; ligand binding 
induces receptor dimerization and phosphorylation. (B) “Rotation/twist model”, 
ErbB receptors exist in inactive dimeric form on native membranes; ligand 
binding results in conformational change of the juxtamembrane domain thus 
to dissociate the kinase domain for phosphorylation.  
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1.3 Intracellular signal processing by Cdc42 
As mentioned in section 1.2, after receptor activation, a variety of intracellular 
signaling proteins become activated and start to process signal transduction. 
As more and more cellular signaling pathways have been identified, it 
becomes clear that signaling pathways do not exist as linear pathways, but 
are organized as complex signaling networks [1]. The interconnection of 
different pathways results from the fact that one signaling protein can receive 
multiple signal inputs and/or split signals to different pathways to regulate 
different cellular functions. Such proteins are called junctions or nodes on the 
signaling networks [1]. Cdc42, a small GTPase from the Rho family, is one 
important downstream node on the networks that regulate multiple cellular 
functions such as cell migration, division and morphogenesis. 
 
1.3.1 Signal transduction: Cdc42 as a signaling node on 
intracellular signaling networks 
Cdc42 plays essential roles in the cell division cycle as its name indicates 
(Cdc represents ‘cell division control’). It receives signals from several 
receptor pathways including the ErbB receptor pathway, and regulates 
multiple cellular tasks through interactions with different effector proteins (56). 
Like other GTPases, Cdc42 acts as a ‘molecular switch’, that is, it regulates 
signaling processes through the transition between two states, the ‘on’ (active) 
and ‘off’ (inactive) states. The ‘off’ state form of Cdc42, i.e. the inactive GDP-
bound Cdc42, locates in the cytoplasm of cells. When mitogenic signals start 
processing, Cdc42-GDP translocates to the plasma membrane. Membrane-
bound guanine nucleotide exchange factors (GEFs) catalyze the removal of 
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GDP and the replacement of GTP, so that Cdc42 turns to its “on” state, the 
active GTP-bound state. Active Cdc42 binds to the target proteins and 
tranduces signals to promote a cellular response. Finally, inactivation of the 
active Cdc42 is achieved by the intrinsic GTP hydrolytic activity accelerated 
by the GTPase activating proteins (GAPs). Therefore, the cycle is completed 
and Cdc42 returns to its inactive GDP-bound state.  
 
The balance between the ‘on’ and ‘off’ states of Cdc42 is precisely controlled 
in the intracellular environment, so that the cell can regulate its essential 
biochemical functions through regulating the activation of Cdc42. The 
Cdc42G12V (denoted as Cdc42V12 in this thesis) induces a GTPase-defective 
phenotype, which has been used as a means of continual stimulation of Rho 
effectors (57). On the other hand, Cdc42T17N (denoted as Cdc42N17) is a 
guanine nucleotide-exchange defective mutant (“dominant-negative” mutant).   
Under the two types of mutations the balance between active and inactive 
forms of Rho GTPases is disrupted, which is normally found in tumor cells 
(58).  
 
Polarization is an essential cellular process during cell proliferation, 
differentiation and migration. Cdc42 is the center of cell polarization (21). 
Multiple receptor pathways regulate activation of Cdc42, including the tyrosine 
kinase receptors like ErbBs, G-protein-coupled receptors and T-cell receptors 
(TcR) (19, 22, 59, 60). These receptors receive external signals such as 
chemotactic signals and physical stress that promote cell polarization, and 
transduce the signals through different intermediates that finally recruit and 
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activate Cdc42. Through interactions with different effector proteins, the 
activated Cdc42 controls multiple signaling pathways that regulate cell 
polarization. These pathways act in regulation of actin and the microtubule 
cytoskeletons, membrane traffic and cell-cell junctions, which constitute the 
spatial and temporal requirements for cell polarization.   
 
1.3.2 Interactions between Cdc42 and its effectors  
As introduced before, Cdc42 regulates multiple cellular functions through 
interactions with different effector proteins. Over twenty types of proteins have 
been reported to bind activated Cdc42 (61-64). These effectors can be 
classified into large groups, such as protein kinases, actin-associated proteins 
and adaptor proteins (65). Many of the effectors contain a conserved 18 
amino-acid binding motif which is named CRIB (for Cdc42-Rac interactive 
binding) motif. Hoffman and Cerione compared the sequences of CRIB motif 
among two kinases, Pak (for p21-activated kinase) and Ack (for activated 
Cdc42-associated tyrosine kinase), and an actin-associated protein WASP 
(for Wiskott Aldrich syndrome protein), and explained the structural basis of 
signaling through the CRIB motif (66).  An adaptor protein, insulin receptor 
tyrosine kinase substrate p53 (IRSp53), has been reported to contain a partial 
CRIB motif which interacts with Cdc42 (62). Govind et al. also reported that 
Cdc42Hs (human Cdc42) localizes IRSp58 to filamentous actin to promote 
neurite outgrowth (63).  The residues of the CRIB sequence on effectors are 
essential for the binding of Cdc42-GTP, while the CRIB motif alone may not 
be sufficient for strong binding to Cdc42 (67).    
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A few other non-CRIB containing proteins have also been identified to interact 
with Cdc42 (64, 68-70). Toca-1 (for transducer of Cdc42-dependent actin 
assembly) has a conserved PCH (for pombe Cdc15 homology) domain which 
includes a FCH (for FER/CIP4 homology) domain at its N terminus and one 
SH3 (Src homology3) domain at its C-terminus. Like many other PCH proteins, 
Toca-1 also contains a HR1 (protein kinase C-related kinase homology region 
1) domain for binding of small GTPases. Ho et al. reported that Toca-1 binds 
both Cdc42 and N-WASP (neural WASP) and mediates in actin nucleation 
through interacting with N-WASP-WIP/CR16 complex (64). Another effector, 
IQGAP1 (IQ motif containing GTPase activating protein 1), contains four 
potential calmodulin-binding IQ domains and a catalytic GAP homology 
domain. Bashour et al. reported that IQGAP1 binds directly to the activated 
form of Cdc42 and Rac, and links the GTPases to the actin cytoskeleton (68). 
Fukata et al. reported that activated Rac1/Cdc42 marks special cortical spots 
for polarized microtubule arrays through interacting with IQGAP1 and CLIP 
(cytoplasmic linker protein)-170 during cell polarization (69). More recently, 
Watanabe et al. proposed a model of the role of IQGAP1 in directional cell 
migration (70). Briefly, extracellular signals like growth factors activate 
membrane receptors, which in turn activate Rac1 and Cdc42 through 
intracellular signal transduction. Activated Rac1 and Cdc42 promote actin 
polymerization through interacting with effectors like WASP and WAVE 
(WASP-family Verprolin-homologous protein). Activated Rac1 and Cdc42 also 
mark the cortical region for IQGAP1 to cross-link actin filaments. IQGAP1 
captures the plus ends of microtubules by interacting with CLIP-170 and 
 16
recruits APC (adenomatous polyposis coli) which stabilizes microtubules at 
leading edges.  
 
   
Fig. 1.2 Cdc42 activation pathways and the interactions of active Cdc42 with 
its effectors. The signaling pathways regulate actin and microtubule dynamics, 
which are essential for cell polarization. Solid arrow, direct interaction. Dashed 
arrow, indirect interaction.   
 
In this study, the interactions between Cdc42 and its known effectors, 
NWASP, IRSp53, and Toca-1, were studied under the same experimental 
setup for comparison. The three effectors are all involved in regulation of actin 
dynamics. NWASP is a CRIB-containing effector, IRSp53 contains a partial 
CRIB motif and Toca-1 is a non-CRIB-containing effector. Therefore, the 
experiments would show whether there is a difference in binding strength 
between Cdc42 and effectors with different Cdc42 binding domains. Fig 1.2 
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shows the Cdc42 interaction network, referred to (21, 62, 63, 71). The 
interactions between Cdc42 and its effectors that were studied in this thesis 
are highlighted in light yellow color.  
 
1.4 Objectives and significance of the study 
The main objective of this study was to apply biophysical fluorescence 
techniques, i.e. FCS and FCCS, to quantitatively study protein-protein 
interactions in live cells. Compared to conventional biochemical methods, 
FCS/FCCS have several advantages. First, FCS/FCCS detect biomolecular 
interactions directly in live cells, so that they avoid large amounts of protein 
purification work. At the same time, FCS/FCCS do not require specific 
reagents like cross-linking reagents or antibodies, hence avoid any reagent-
dependent artifacts. Second, FCS/FCCS are non-invasive methods as target 
proteins can be genetically tagged with fluorescent probes. In addition, 
FCS/FCCS detect molecular interactions in a small confined observation 
volume (at sub-femtoliter range) with high sensitivity (at the single-molecule 
level) (72). Thus there is little perturbation on the studied systems. This 
provides an opportunity to monitor biomolecular interactions in situ in live cells, 
tissues or even living organisms. For instance, fluorescent proteins can be 
genetically tagged to proteins in zebra fish embryos, so that one can monitor 
the target protein during fish development. Such in vivo monitoring 
experiments are difficult to perform by other conventional techniques. Besides, 
high temporal resolution is another advantage of FCS/FCCS. FCS/FCCS can 
be applied to study molecular dynamics from nanosecond to second time-
range, including rotational diffusion at nanosecond time-range, photophysical 
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and photochemical dynamics of fluorescent probes at microsecond time-
range, and translational diffusion from microsecond to second time-range. 
Most important of all, FCS/FCCS provide quantitative information on 
molecular interactions, which can seldom be provided by other methods. The 
next chapter will introduce the theory of FCS/FCCS to determine 
concentration, mobility, binding strength and other important information of 
interacting molecules.  
 
Although both methods have been established, a large portion of FCS/FCCS 
work was done in vitro, and the applications of FCS/FCCS on studies of 
biomolecular interactions in live cells are limited. In particular, single 
wavelength excitation fluorescence cross-correlation spectroscopy (SW-
FCCS), established by Hwang and Wohland (34, 73-75), had not been 
applied to study molecular interactions in live cell systems. In this thesis, we 
further developed SW-FCCS to study protein-protein interactions in vivo. In 
addition to the advantages of conventional FCCS such as non-invasiveness 
and single-molecule sensitivity, SW-FCCS overcomes the difficulty of aligning 
two laser lines into one focal spot or the expensive cost of using a pulsed 
laser (73). Most importantly, quantitation of interactions in vivo is the key 
advantage of the technique. In this thesis we introduced the analytic methods 
to quantify biomolecular interactions through SW-FCCS measurements, which 
reveal SW-FCCS as a potential screening technique to monitor molecular 
interactions in vivo.  
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Two biological systems were investigated here: the ErbB receptor family and 
Cdc42-related signaling complexes. Both systems are involved in cellular 
signal transduction. ErbB receptors receive signals from outside the cells and 
initiate intracellular signal transduction. Cdc42 is one important intracellular 
signaling node which receives signals from many receptors and then splits the 
signals to different pathways. Both ErbB receptors and Cdc42 are involved in 
signaling pathways that regulate cell proliferation and differentiation. For the 
ErbB family, our target was to investigate the interactions between the 
receptors before ligand binding, which are crucial for the activation of the 
receptors.  For the Cdc42 interacting complexes, our target was to examine 
the difference in the interactions between Cdc42 and effectors with different 
binding domains. The ErbB receptors locate on the cell surface, and Cdc42 
and effectors distribute in the cytoplasm of the cell. Therefore, by performing 
SW-FCCS on the two groups of proteins, the whole study may reveal SW-
FCCS as a versatile technique in detecting protein-protein interactions in live 
cells.  
 
The activation mechanism of ErbB receptors is of fundamental importance for 
anti-cancer drug design. It is well-known that overactivation of the ErbB family 
tyrosine kinase activity is frequently implicated in a variety of human cancers 
(76). A certain portion of anti-cancer drugs in development are targeting 
receptor tyrosine kinases, as inhibition of the overactivation of the kinases can 
effectively inhibit tumor progression. For example Gefitinib, one tyrosine 
kinase inhibitor which targets ErbB1/ErbB2, can stop tumor progression and 
even cause tumor regression and metastasis (77). The actual activation 
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mechanism of the ErbB receptors is still under discussion, although different 
models have been proposed. Crystal structures of the extracellular domain 
and kinase domain of the receptors show that the active form of the receptors 
is a dimeric complex (42, 47).  Before ligand stimulation, however, it remains 
controversial whether the receptors exist in monomeric or dimeric structure on 
cell membrane. Therefore, we set out to investigate if there are homo- & 
heterodimeric structures of ErbB1 and ErbB2 on live cell membrane by using 
FCS and FCCS. The discovery of the activation mechanism may help in drug 
development. For instance, if the receptors preform dimeric structures on 
native cell membrane, and ligand binding induces conformational changes of 
the transmembrane and cytoplasmic domains of the receptor instead of 
inducing receptor dimerization, then it may be more efficient to develop small 
chemicals or monoclonal antibodies (mAbs) that target the extracellular 
domain (ectodomain) of the receptor. As the structure of the extracellular 
domain of the receptor has already been determined (42), drugs designed 
specifically according to the structure of the ectodomain may inhibit the 
receptor activation more efficiently. Another advantage of such drugs is that 
since they target the ectodomain of the receptors, the drugs avoid the process 
of passing through the cell membrane barrier, which is one major problem of 
drug delivery.   
 
Rho GTPases, including Rac and Cdc42, are critical factors that regulate the 
regeneration of the central neuron system (CNS) (78).  It is known that axons 
in the CNS of mammals do not regenerate after injury, which is associated 
with nerve system diseases such as Parkinson’s disease and Alzheimer’s 
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disease. The regeneration is blocked by CNS myelin which contains several 
growth inhibitory proteins. Therefore, it is important to neutralize these 
inhibitory effects to promote efficient axon regeneration. As many ligands and 
receptors mediate the inhibition by CNS myelin and the glial scar, to design 
drugs that target individual components might not be the most efficient way to 
overcome the inhibitory influences. As introduced in chapter 1.3, Cdc42 is one 
common intracellular signaling node on multiple pathways that regulate actin 
and microtubule cytoskeleton in both non-neuronal and neuron cells. It has 
been reported that the activation of RhoA stimulates actomyosin contractility 
and stress fiber formation which results in growth cone collapse, while the 
introduction of Cdc42 and Rac1 leads to the extension of filopodia and 
lamellipodia in neuronal cell lines. Thus, the studies on interactions between 
Cdc42 and its effectors may help to identify novel signaling pathways that are 
common to multiple inhibitory sources, and thus may offer a greater prospect 
for promoting axon regeneration.   
 
In summary, this thesis will examine the interactions of two sets of signaling 
proteins, one from the receptor tyrosine kinase family and the other from the 
Rho GTPase family.  Both of the two studies have potential values for disease 
treatment. The methods we used for the study were fluorescence techniques, 
including FCS and FCCS. SW-FCCS had not been applied to study molecular 
interactions in live cells. In this study we further applied SW-FCCS to study 
protein-protein interactions in vivo, which may develop SW-FCCS as a novel 
screening method for detecting molecular interactions in biological system.  A 
more detailed literature review of FCS/FCCS/SW-FCCS methods will be given 
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in the next chapter. The limitations of the methods will be discussed 
accordingly in subsequent chapters.  
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Chapter 2  
FCS/FCCS Theory, Application and Experimental Setup 
 
FCS is an experimental technique that uses statistical analysis of the 
fluctuations of fluorescence to investigate dynamic molecular processes in a 
confined focal volume. The processes that cause fluctuations of fluorescence 
include translational diffusion of fluorescent particles, as well as photodynamic 
processes such as intersystem crossing to the triplet state and conformational 
fluctuations of fluorophores. FCS was first invented to study chemical kinetics 
of the binding/unbinding reactions between ethidium bromide and DNA (79), 
and it has become a versatile technique in chemistry, biophysics and cell 
biology (72, 80-86).  More recently, a number of FCS applications for the 
study of subcellular components in live cells have been reported, which are of 
special interest to us (87-98).  
 
The cross-correlation concept was first introduced to analyze laser light-
scattering fluctuations (99). Rotational diffusion of particles can be determined 
by cross-correlation between two detectors (86).  Most importantly, FCCS is a 
direct and quantitative method to study biomolecular interactions. Dual-color 
FCCS has been applied to monitor enzyme kinetics in vitro as well as in vivo 
(100-102). The theory of SW-FCCS for binding studies has been established 
and has been applied to study biomolecular interactions in vitro (34, 73, 75). 
The focus of this chapter is the introduction of the relevant parts of SW-FCCS 
theory that were used to quantify the interactions of the biological systems 
that we studied in this thesis.  
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Both FCS and SW-FCCS experiments in this thesis were carried out on an 
optical setup based on a modified Zeiss Axiovert 200 microscope (34). In this 
section we introduce the optical setup for each fluorescent protein (FP) in 
FCS and SW-FCCS measurements. Calibration of the system using standard 
dyes is also introduced in this chapter and the handling of biological samples 
for FCS/FCCS measurements will be introduced in the next chapter. 
 
2.1    FCS theory and applications 
2.1.1 The theory of FCS 
Assuming constant excitation power, the fluctuations of the fluorescence 
signal are defined as the deviations from the temporal average of the signal 
(87):     
( ) ( ) ( )F t F t F tδ = −                                                                                       (2.1) 
dttF
T
tF
T∫= 0 )(1)(                                                                                         (2.2) 
Here ( )F t  is the detected fluorescence intensity and ( )F t  denotes the mean 
fluorescence intensity.  
The autocorrelation function (ACF) is defined as: 
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Depending on the molecular processes which cause the fluorescence 
fluctuations, ( )G τ
 
will have a characteristic form (103-106). For example, in 
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the case of a free three-dimensional (3D) translational diffusion of a single 
species, ( )G τ
 
is derived as (103, 107): 
1/ 2
2
1 1 1( )
1 1
diff diff
G G
N
z
τ τ ω ττ τ
∞
⎛ ⎞⎛ ⎞⎜ ⎟⎜ ⎟⎜ ⎟⎜ ⎟= +⎜ ⎟⎜ ⎟ ⎛ ⎞+ ⎜ ⎟+⎜ ⎟ ⎜ ⎟⎜ ⎟⎝ ⎠ ⎝ ⎠⎝ ⎠
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G∞  is the limiting value of ( )G τ , i.e. when τ →∞ , and its value is normally 1.  
N  is the average number of particles in the effective observation volume, i.e., 
the confocal volume in a confocal setup. ω and z  are the radial and axial 
distances of the focal volume at which the laser excitation intensity has 
dropped by 1/e2 of the maximum intensity. diffτ  is the diffusion time of 
fluorescent particles, i.e. the average residential time of fluorescent particles 
in the focal volume, which is given by: 
2
4diff D
ωτ =                                                                                                       (2.5)                     
From Eq. (2.4), given τ =0, we have: 
(0) 1/G N G∞= +                                                                                              (2.6) 
From Eq. (2.6) the number of particles in the observation volume ( N ) is 
determined. 
 
Chemical fluorescent dye molecules have a characteristic triplet state 
relaxation time at submicrosecond time-range. Including the term of the triplet 
state, ( )G τ
 
is given by: 
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 26
tripτ  is the triplet state relaxation time of fluorophores; tripF  is the fraction of 
fluorescent particles that stay in the triplet state; K  is defined as the structure 
factor which equals z ω .  Eq. (2.7) is the fitting model that is normally used 
to calibrate the system using a standard chemical dye, such as fluorescein for 
the calibration of the 488nm laser line, rhodamine 6G for the calibration of the 
514nm laser line, and tetra methylrhodamine (TMR) for the calibration of the 
530nm laser line.  
 
Fluorescent proteins are widely employed in biological research since they 
can be genetically tagged to target proteins with minimum disturbance of the 
biological system (108-110). Compared to small chemical dyes, FPs are 
relatively large molecules and hence they exhibit more complicated 
photophysical and photochemical processes with identical time-ranges from 
sub-picoseconds to seconds and minutes (111-114).  Particularly, the 
photodynamic properties of the green fluorescent protein (GFP) and its variant 
F64L S65T (EGFP, for enhanced green fluorescent protein) have been 
extensively studied (86, 114-123). In addition to the intersystem crossing from 
singlet state to the triplet state, EGFP shows several photodynamic processes 
with characteristic times ranging from several microseconds to hundreds of 
microseconds. Those additional photodynamic processes include a reversible 
photo-isomerization and conformational changes induced reversible 
transitions, as well as proton transfer. As the additional photodynamic 
processes are in similar time-ranges and not quite distinguishable especially 
in live cell measurements, we simply added one more exponential decay term 
in the fitting model to represent those photodynamic processes: 
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Here dynaF  is the fraction of fluorophores in the additional photodynamic 
processes and dynaτ  signifies the characteristic time of the photodynamic 
processes. The dynaτ  value fitted by Eq. (2.8) will depend on which 
photodynamic process dominates.  
 
The above equations are all based on 3D diffusion of single species. In the 
case of membrane proteins, the motion is in two dimensions (2D) so that the 
term for the motion in z  direction is eliminated:  
1
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Eqs. (2.8) and (2.9) are the main fitting models that were used to fit the ACFs 
of the FCS/FCCS measurements in this thesis. Note in some occasions the 
triplet state of the fluorophores may be deactivated by internal quenching (86), 
so that the fitting models can be simplified with only one exponential decay 
term. There are also a number of other fitting models which correspond to 
different experimental conditions, such as flow models for fluorescent particles 
diffusion in a flow channel and models for diffusion of multi-species. Several 
review papers introduce comprehensive theoretical models for FCS (30, 72, 
84, 124-126).  
 
Fig. 2.1 explains how the parameters are obtained by fitting the raw data 
points from FCS measurements. The green dashed curves are raw data 
points generated from correlator and the solid green curves are the fitted 
curves according to the above mentioned mathematic models. Fig. 2.1 (A)  
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Fig. 2.1 ACFs of the diffusion of one species with one triplet state and one 
additional photodynamic process. (A) Parameters are obtained through fitting 
raw data points with the three-dimensional diffusion model (Eq. 2.8). (B) The 
amplitudes on Y axis decreases with the increase of particles in the focal 
volume. (C) ACFs shift towards right with the increase of diffusion time.  
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shows three dynamic parameters tripτ , dynaτ , and diffτ  are obtained from the 
three decays from different dynamic processes of the particles. The 
corresponding values on the X axis (pointed out by dashed blue arrows) 
exhibit the time-ranges of these processes. On the other hand, from the      
amplitudes on the Y axis the number of particles in the focal volume N  is 
obtained. Note that in the global fitting models the total number of particles N  
is determined by the amplitude of the lowest decay of the ACF curve, i.e. the  
amplitude of the decay of translational diffusion. The fractions between 
different processes are calculated from the ratio between the intercepts of the 
different processes, i.e. tripF , dynaF  and diffF  are obtained (note tripF  is not 
shown on figure as the ACF shows only times longer than at 10-6 s and the full 
amplitude of the triplet cannot be seen).  Fig. 2.1 B shows that with the 
increase of the concentration of particles, the amplitudes (0)G  decreases (Eq. 
2.5). If the diffusion time increases, the ACF curve shifts to right (Fig. 2.1 C). 
 
2.1.2 Applications of FCS 
From fitting the raw data points with proper fitting models, several valuable 
parameters are obtained, such as N , diffτ  and tripτ , and hence different 
categories of  the applications of FCS are realized (127). Theoretically, the 
absolute local concentration of fluorescent particles can be determined if the 
size of the effective observation volume effV  is known (30, 32): 
/ effc N V=                                                                                                     (2.10) 
From Eq. (2.10) one may think that effV  can be determined by calibrating the 
system using a standard dye solution with a known concentration. However, 
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at very low concentrations such as nanomolar the number of particles in the 
focal volume N  may be affected by several factors, such as precipitation of 
the dye molecules on the cover slips or photobleaching of the fluorophores. 
Therefore the effV  determined may not be accurate and the absolute local 
concentration of target molecules can not be determined precisely. 
Alternatively, the diffusion coefficient of fluorescent particles is not depending 
on concentrations. If the diffusion coefficient of standard dye molecules is 
accurately determined by other techniques, z  and ω  can be calibrated by 
using the parameters diffτ  and zω   from fitting the autocorrelation curve. 
Therefore a relative local concentration of target molecules can be determined. 
This is the first category of FCS applications, i.e., to determine the 
concentration of fluorescent or fluorescence-labeled particles (32, 128-130). 
By monitoring the concentrations of fluorescence-labeled molecules, it is 
possible to investigate the kinetics of chemical reactions, such as interactions 
between ligands and receptors (31, 131-133), enzyme kinetics (134), and 
DNA reactions (135). For example, Pramanik and Rigler used Rh-EGF to plot 
the association/dissociation constants between EGF and the receptor, and the 
results suggested there may be two different forms of EGF receptors (31).  
 
Besides, from N  and the average fluorescence intensity (count rates) in the 
detection channel, the brightness of fluorescent molecules can also be 
calculated:  
( )F t
Nη =                                                                                                 (2.11)                 
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The brightness η  is also put in as counts per molecule per second (cps). This 
parameter is often used to quantify the performance of fluorescent probes and 
also as an important parameter to indicate the calibration quality of a setup. 
The application of η  from FCS is limited in cell measurements due to 
autofluorescence background in cells, stability of fluorescent probes or 
aggregation of target proteins. The following two equations were introduced to 
correct the background effect on brightness η  and number of particles N  (85): 
2 2/( )meas meas meas BF F Fη η= 〈 〉 〈 〉 − 〈 〉                                                                  (2.12) 
2 2/( )meas meas meas BN N F F F= 〈 〉 〈 〉 − 〈 〉                                                                (2.13) 
measF  denotes the measured fluorescence intensity of cell samples that 
expressing FPs and BF  denotes the autofluorescence background of 
untransfected cells. From the above equations we can see that if the 
fluorescence background is far below the fluorescence intensity of the cell 
samples, i.e. BF << measF , the background effect is negligible. On the other 
hand, if the two values are comparable, such as at very low expression level 
the fluorescence intensity is close to the background value, then  BF  will 
have a great effect on η  and N . Other relative methods such as photon 
counting histogram (PCH) and fluorescence intensity distribution analysis 
(FIDA) are more widely applied to determine the molecular brightness η  in 
live cells (119, 136, 137).    
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The second important parameter from FCS is the translational diffusion time 
diffτ . The diffusion coefficient D  can be obtained using the following equation 
(107): 
2
4 diff
D ωτ=                                                                                                     (2.14) 
This parameter signifies the mobility of fluorescent or fluorescence-labeled 
molecules, which can be applied directly to study the mobility of subcellular 
compartments (89, 93-95, 98, 133, 138-140). For example, Bacia et al. 
studied the dynamics of membrane rafts by measuring the diffusion 
constant D  (89). Furthermore, the difference in diffτ  between bound and non-
bound particles was utilized to study the binding reactions by using a two-
component fitting model (141).  
 
The diffusion constant D  can be employed to calculate the hydrodynamic 
radius R  of particles in a medium with viscosity of visη  at temperatureT : 
6 vis
kTD
Rπη=                                                                                                 (2.15) 
k  is Boltzmann’s constant.  Werner et al. studied the folding process of 
cytochrome c through monitoring changes of its hydrodynamic radius R  at 
different pH values by FCS (142). In addition, the radius R  is related to the 
mass of particles: 
3
3
4 A
mR
Nπρ=                                                                                                (2.16) 
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AN  is Avogadro’s number and ρ is the mean density of the molecule. Thus 
the diffusion constant D  is inversely proportional to the cubic root of the mass 
of particles m , i.e.: 
3
1D
m
∝                                                                                                       (2.17)  
Based on this, Krouglova et al. studied the tubulin oligomerization process by 
FCS (143).  
 
Another important application of FCS is to study photophysical and 
photochemical properties of fluorescent probes by analyzing the characteristic 
time of photodynamic processes, such as tripτ  and dynaτ  (86, 111, 114, 144-
146).  These parameters are related to the structure of chromophores and can 
be affected by environmental factors such as changes of pH. For instance, 
Haupts et al. studied the protonation process of EGFP by using FCS (146). 
They found that the characteristic time of protonation of EGFP decreased 
from 300 μs at pH 7.0 to 45 μs at pH 5.0. At the same time, the fraction of 
molecules in the nonfluorescent state are given by tripF  and dynaF . In addition, 
the brightness of fluorescent probes can be calculated using Eq. (2.11), which 
indicates the fluorescence yield of fluorescent probes. Consequently, the 
performance of fluorescent probes, including chemical dyes and fluorescent 
proteins, can be evaluated through studying their photodynamic properties by 
FCS.  
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2.2    FCCS theory and applications 
2.2.1 The theory of SW-FCCS 
As introduced before, FCS can be applied to study the binding between 
fluorescence-labeled ligand and receptors through observation of the change 
in diffτ  after binding. However, to distinguish two components by FCS 
requires at least a factor of 1.6 difference in diffτ  (107), which in turn requires 
at least four to eight times change in mass after binding (Eq. (2.17)). This 
limits the application of FCS to detect biomolecular interactions, especially 
when two interacting molecules are similar in mass. Instead, FCCS detects 
interactions by simultaneous detection of two different fluorescence-labeled 
molecules, which does not depend on the difference in mass.  
 
Cross-correlation is normally carried out between two fluorescent species, 
one with a shorter wavelength fluorescence label (referred to as green 
fluorescence label) and one with a longer wavelength fluorescence label 
(referred to as red fluorescence label).  The normalized CCF is given by: 
( ) ( ) ( ) ( )
( ) 1
( ) ( ) ( ) ( )
g r g r
x
g r g r
F t F t F t F t
G
F t F t F t F t
δ δ τ ττ + += = −                                              (2.18) 
Here ( )xG τ  represents the cross-correlation of signals between the green 
channel and red channel, ( )gF t  represents the fluorescence intensity in the 
green channel and ( )rF t  represents the fluorescence intensity in the red 
channel.      
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A typical dual-color FCCS setup consists of a confocal system in which two 
excitation laser lines are aligned to focus on the same spot in the sample (33). 
However, it is technically difficult to align two laser lines with different 
wavelengths to overlap each other (80). This lead to the alternative setup of 
two-photon excitation FCCS using an infrared (IR) laser (147). The limitation 
of the two-photon system is that the cost is much higher due to the expensive 
IR pulsed laser. Alternatively, a system of two fluorophores with similar 
excitation wavelength but with different Stokes shifts was suggested (147, 
148). Such system is simplified by using one laser line (single-wavelength) 
one-photon excitation, and it avoids the difficulty of the alignment of two laser 
lines or the cost of using an expensive pulsed laser. Hwang and Wohland 
developed the theory of SW-FCCS and successfully applied the SW-FCCS 
instrument to detect ligand-receptor binding in vitro (34, 73, 75). Here we 
introduce the theory of SW-FCCS in detail as it was the major method we 
used to study protein-protein interactions in vivo in this thesis. 
 
First let us consider a relatively simple study system, i.e. two molecules are 
labeled with green and red fluorescence tags, respectively. The binding 
between the two molecules is 1:1, i.e. one green fluorescence-labeled 
molecule binds to one red fluorescence-labeled molecule. Considering the 
cross-talk between two channels, the fluorescence intensity in each channel is 
given by: 
( ) G G R R GR GRg g g gF t c c cη η η= + +                                                                        (2.19) 
( ) R R G G GR GRr r r rF t c c cη η η= + +                                                                        (2.20) 
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The sample is composed of three species, free green particles with a 
concentration Gc , free red particles with a concentration Rc , and bound 
complex with a concentration GRc . The fluorescence intensity in the green 
channel ( )gF t  is attributed to three species, the fluorescence emission of free 
green particles, which equals the molecular brightness (cps) of free green 
particles in the green channel Ggη times the concentration of free green 
particles Gc ; the cross-talk of fluorescence emission of free red particles into 
the green channel, which equals the molecular brightness of red particles in 
the green channel Rgη  times the concentration of red particles Rc ; and the 
fluorescence emission of the  bound complex with concentration grc , which 
equals the brightness of the complex in the green channel GRgη  times the 
concentration of the complex  GRc . Similarly, the fluorescence intensity in the 
red channel ( )rF t  is given by the three species, respectively (Eq. (2.20)).  
 
Putting Eq. (2.19) and Eq. (2.20) into Eq. (2.18) and assuming the focal 
intensity profile is Gaussian profile in all three axes, the CCF can be 
calculated (106, 149): 
( ) ( )( )
( )( ) 1
0
G G G R R R GR GR GR
g r g r g r
x G G R R GR GR
A eff g g g g A eff
G G R R GR GR
r r r r A eff
c c c
G
N V c c c N V
c c c N V
η η η η η η
η η η β
η η η β −
+ += + + +
× + + +
                                   (2.21) 
Here AN  is Avogadro’s number and Veff is the effective observation volume, 
i.e. the confocal volume. gβ  and rβ  represent the autofluorescence 
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background in the green channel and red channel, respectively. At the same 
time, the two ACFs in the green channel and red channel are given by: 
( ) ( ) ( ) ( ) ( )( )
2 2 2
20
G G R R GR GR
g g g
g
G G R R GR GR
A eff g g g g A eff
c c c
G
N V c c c N V
η η η
η η η β
+ +=
+ + +
                                 (2.22)     
( ) ( ) ( ) ( ) ( )( )
2 2 2
20
G G R R GR GR
r r r
r
G G R R GR GR
A eff r r r r A eff
c c c
G
N V c c c N V
η η η
η η η β
+ +=
+ + +
                                  (2.23)     
The values of ( )0xG , ( )0gG  and ( )0rG  are obtained directly from fitting the 
two ACFs and the CCF of SW-FCCS measurements. The molecular 
brightness (cps) of each species and background values can be obtained 
through calibration of the system. Thus it is possible to numerically solve Eq. 
(2.21), Eq. (2.22) and Eq. (2.23) and obtain the values of Gc ,  Rc  and GRc . 
Furthermore, the percentage of bound complex can be calculated from the 
three concentrations, i.e. how many percentages of green particles are 
forming complex with red particles:  
GR
G
G GR
cf
c c
= +                                                                                              (2.24) 
Or the percentage of red particles that form complex with green particles: 
GR
R
R GR
cf
c c
= +                                                                                               (2.25) 
The complex percentages calculated by Eq. (2.24) and (2.25) depends on the 
relative concentrations of Gc  and Rc . For example, if the total concentration of 
green particles is much larger than that of the red particles, then GR Gc c , 
and Gf  will be a very small value. Alternatively, the dissociation constant DK  
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at equilibrium is not affected by the relative concentrations of the green and 
red particles: 
G R
D GR
c cK
c
×=                                                                                                (2.26) 
From the DK  we can estimate the interaction strength between two molecules. 
In this thesis, we applied the above equations to investigate the interactions 
between Cdc42 and its effector proteins. 
 
Let us further consider a more complicated situation. Many cell membrane 
receptors are known to form dimeric structures, such as the insulin receptors 
(150), erythropoietin (EPO) receptor (151) and most G protein-coupled 
receptors (GPCRs) (152). To study the dimeric form of receptors, one can 
label the receptor with either a green fluorescence tag or a red fluorescence 
tag. Assuming the fluorescence tag does not affect the ability of receptors to 
form dimeric structures, the possibility of two green fluorescence labeled 
receptors forming a dimer or two red fluorescence labeled receptors forming a 
dimer, should equal the possibility of one green fluorescence labeled receptor 
and one red fluorescence labeled receptor forming a dimer. In this case, the 
fluorescence intensity in the each channel is given by 
( ) G G R R GG GG RR RR GR GRg g g g g gF t c c c c cη η η η η= + + + +                                   (2.27) and  
 ( ) R R G G RR RR GG GG GR GRr r r r r gF t c c c c cη η η η η= + + + +                                        (2.28), 
respectively. Here Gc  and Rc  represent the concentrations of monomeric 
receptors and GGc , RRc  and GRc  represent the concentration of dimeric 
receptors. Ggη , Grη , Rrη  and Grη  are the same as introduced before. GGgη  
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represent the molecular brightness of homodimeric green fluorescence 
labeled receptors in the green channel, and RRgη  represent the crosstalk of the 
fluorescence emission of homodimeric red fluorescence labeled receptors into 
the green channel. Similarly, RRrη  represent the cps of homodimeric red 
receptors in the red channel and GGrη  represent the crosstalk of the 
fluorescence emission of homodimeric green receptors into the red channel. 
Hence the CCF between the two channels is give by: 
( ) ( )( )
( )( ) 1
0
G G G R R R GG GG GG RR RR RR GR GR GR
g r g r g r g r g r
x G G R R GG GG RR RR GR GR
A eff g g g g g g A eff
G G R R GG GG RR RR GR GR
r r r r r r A eff
c c c c c
G
N V c c c c c N V
c c c c c N V
η η η η η η η η η η
η η η η η β
η η η η η β −
+ + + += + + + + +
× + + + + +
      (2.29)   
 And the two ACFs are: 
( ) ( ) ( ) ( ) ( ) ( )( )( )
2 2 2 2 2
20
G G R R GG GG RR RR GR GR
g g g g g
g
G G R R GG GG RR RR GR GR
A eff g g g g g g A eff
c c c c c
G
N V c c c c c N V
η η η η η
η η η η η β
+ + + +=
+ + + + +
    (2.30) 
( ) ( ) ( ) ( ) ( ) ( )( )( )
2 2 2 2 2
20
G G R R GG GG RR RR GR GR
r r r r r
r
G G R R GG GG RR RR GR GR
A eff r r r r r r A eff
c c c c c
G
N V c c c c c N V
η η η η η
η η η η η β
+ + + +=
+ + + + +
     (2.31) 
The total concentration of receptors on the cell membrane is: 
2( )G R RR GG GRtotc c c c c c= + + + +                                                                   (2.32) 
The possibility of the receptors to form dimers is given by Dp  and it is the 
same for both homo- and heterodimers as it depends only on the receptor 
itself but does not relate to the fluorescence tags (for experimental 
confirmation see Chapter 5.3). The probability to find a green fluorescence 
labeled receptor is: 
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2G GG GR
G
tot
c c cp
c
+ +=                                                                                    (2.33) 
And the probability to find a red fluorescence labeled receptor is: 
2R RR GR
R
tot
c c cp
c
+ +=                                                                                     (2.34) 
So the concentration of green fluorescence labeled receptors that form 
homodimers is: 
2GG
D G totc p p c=                                                                                            (2.35) 
Similarly,  
2RR
D R totc p p c=                                                                                             (2.36) 
totRGD
GR cppp2c =                                                                                       (2.37) 
Thus we have 
( )22 2 2
GG G GG GR
G
GR R RR GR
R
pc c c c
pc c c c
+ += = + +                                                                    (2.38) 
( )22 2 2
RR R RR GR
R
GR G GG GR
G
pc c c c
pc c c c
+ += = + +                                                                   (2.39) 
Eqs. (2.29-2.31, 2.38, 2.39) can be numerically solved for , , ,G R GG RRc c c c  , and 
GRc . Consequently, the percentage of receptors that form dimeric structures 
can be calculated by: 
( )2 GG RR GRdi
tot
c c c
f
c
+ +=                                                                               (2.40) 
 
The above mathematical model is the one we used to study the dimerization 
of ErbB family receptors on cell membranes. Comprehensive mathematical 
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models have also been derived for more complicated systems, such as 
several ligands binding to one receptor (34, 75) .  
 
Fig. 2.2 shows the examples of FCCS measurements with positive and 
negative interactions. Three functions are obtained from FCCS 
measurements, autocorrelation in the green channel gACF , autocorrelation in 
the red channel rACF , and cross-correlation between the two channels CCF . 
Assuming similar concentrations of green and red particles, i.e. g rN N≈ , the 
CCF is approaching the two ACFs when the two particles interact with each 
other, i.e. positive CCF (Fig. 2.2 A). On the other hand, if there is no 
interaction between the two particles, the CCF will approach 1, which is the 
uncorrelated background level on the Y axis (Fig. 2.2 B). 
 
 
Fig. 2.2 Examples of positive CCF and uncorrelated background CCF. Green 
curves, autocorrelation in the green channel. Red curves, autocorrelation in 
the red channel. Blue curves, cross-correlation between the two channels. (A) 
Positive CCF. The CCF is approaching the two ACFs. (B) Background CCF. 
The CCF is approaching 1, which is the uncorrelated background level on the 
Y axis.  
 
2.2.2 FCCS applications 
Traditional dual-color FCCS, i.e. using either two laser lines or a pulsed two-
photon laser for excitation, has been employed to study biomolecular 
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interactions both in vitro and in vivo (147, 148, 153-158). One typical example 
of in vitro application of FCCS is the study of binding between the 
transcription activator NtrC (nitrogen regulatory protein C) and the 59 bp ES-2 
DNA duplex (157). In the report CCF was derived according to the interacting 
complex and quantitation of the binding percentages was performed, which 
shows that FCCS is a powerful quantitative method to study biomolecular 
interactions. Another example of dual-color FCCS application in vitro is 
reported by Kettling et al. (100). In the report an endonucleolytic cleavage 
reaction was monitored through FCCS measurements at different time points. 
This indicates that FCCS is applicable for in situ monitoring of reaction 
kinetics.  
 
In vivo applications of dual-color FCCS include studies on enzyme activities 
(102, 159), interactions between intracellular signaling proteins (158, 160-163), 
and intracellular trafficking (164). Similar to the in vitro assays, quantitation of 
the concentrations of protease products was performed in live cells (159). In 
the report by Kim et al. on the intracellular interaction between calmodulin 
(CaM) and Ca2+/CaM-dependent protein kinase II (CaMKII), CCF was further 
derived to investigate the binding stoichiometry of CaM and CaMKII (158). 
This in turn shows that FCCS is feasible to study binding stoichiometry 
between different binding proteins in vivo.   
 
Similarly, dual-color FCCS using single-wavelength laser excitation, i.e. SW-
FCCS, is applicable to study biomolecular interactions both in vitro and in vivo. 
Since two fluorophores are excited at the same wavelength, it is possible that 
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one fluorophore may be excited more efficiently so that its signal may give 
relatively higher crosstalk to the other channel. Thus in SW-FCCS crosstalk 
between the two channels must be taken into account. Hwang and Wohland 
developed the comprehensive theory of SW-FCCS (34) and successfully 
applied SW-FCCS to study the binding stoichiometry between fluorescein-
labeled biotin and quantum red-labeled streptavidin (73). By developing a new 
fluorescent protein variant with large Stokes shift, Kogure et al. showed the 
first SW-FCCS measurement in live cells (165). The variant, named as Keima, 
absorbs maximally at 440nm and emits maximally at 620nm. Cyan fluorescent 
protein (CFP) has a similar excitation wavelength maximum at 434nm but 
emits at 477nm. Thus in the paper the two proteins were combined as a pair 
for SW-FCCS application. However, CFP is known to be not as photostable 
as EGFP (166). In this thesis, EGFP and monomeric red fluorescent protein 
(mRFP) are combined as a pair for SW-FCCS investigation of protein-protein 
interactions in live cells, as the two proteins are relatively more stable and 
they also have well-separated emission spectra.    
 
2.3    FCS and SW-FCCS setups 
2.3.1 FCS setup 
Both FCS and SW-FCCS setups were based on a modified Zeiss Axiovert 
200 inverted microscope (Carl Zeiss, Singapore). The different part between 
FCS and SW-FCCS setups is the detection part; FCS uses one detection 
channel while SW-FCCS uses two detection channels. Fig. 2.3 (left) explains 
the basic principle of FCS. A small focal volume (~0.35 femtoliter) is defined 
by using a high numerical aperture (NA) objective (85). The detection volume 
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ensures a high sensitivity, i.e. a single particle motion that causes fluctuations 
of the fluorescence can be detected. The fluorescence fluctuations are 
recorded with time, as shown in Fig. 2.3 B. Thus an ACF is obtained and by 
fitting the raw data points parameters like N , tripτ  and diffτ  are obtained. 
 
Fig. 2.3 (right) shows the optical setup of our self-built FCS. For FCS 
measurements on FPs and FP-fusion proteins in live cells, an argon krypton 
laser (Melles Griot, Singapore) with multiple laser lines was used. Excitation 
wavelength of 488nm was selected for EGFP, and 514nm and 530nm were 
selected for EYFP and mRFP, respectively. A series of neutral density filters 
(Linos, Heidelberg, Germany) was placed in the laser pathway to adjust the 
laser power. The laser beam was expanded by two achromat lenses, f =20 
mm and f =80mm (Linos), and coupled into the microscope. The laser beam 
was reflected by a dichroic mirror and focused by a water immersion objective, 
C-apochromat 63×/1.2NA (Zeiss), into the sample. A 505DRLP dichroic mirror 
(Omega Optical, Brattleboro, VT) was used for 488nm laser line, 525DRLP 
(Omega) was used for 514nm laser line and 560DRLP (Omega) was used for 
530nm laser line. The fluorescence emission was collected by the same 
objective and transmitted through the same dichroic mirror. A 50 μm pinhole 
(Linos) was placed at the image plane of the emission beam to spatially filter 
out light not coming from the focus spot, i.e. the confocal volume in (A). An 
emitter (bandpass filter) was placed in front of the avalanche photodiode 
(SPCM-AQR-14, Pacer Components, Berkshire, UK) to further restrict the 
wavelengths of the fluorescence emission of samples. For EGFP, 505AF23 
(Omega) bandpass filter was used, and 545AF35 (Omega) and 595AF60 
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(Omega) were used for EYFP and mRFP, respectively. The fluorescence 
signals were autocorrelated by a hardware correlator Flex-02-12D 
(correlator.com, Zhejiang, China). The correlation curves were fitted with the 
Levenberg-Marquardt algorithm using Igor Pro software (Wavemetrics Inc., 
Oregon, USA).  
 
 
Fig. 2.3 FCS optical setup designed and constructed in our laboratory. (right) 
the optical setup of FCS. (left) Figure illustration of the basic principle of FCS. 
(A) The confocal volume (enlarged for better visualization). Fluorescent 
particles with free Brownian motion pass through the focal volume, resulting in 
fluorescence fluctuations in (B). Correlating identical fluctuations with time 
gives the ACF curve in (C). By fitting the ACF curve parameters like N , tripτ  
and diffτ  are obtained, which provide valuable information such as 
concentrations and motility of the fluorescent particles. NF, neutral density 
filter; AC, apochromat; DC, dichroic mirror; APD, avalanche photodiode. 
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2.3.2 SW-FCCS setup 
SW-FCCS was based on the same setup for FCS, except that in the detection 
part two channels were set up for the detection of two fluorescence emissions. 
Fig. 2.4 (right) shows the SW-FCCS setup. The excitation setup was the 
same as that of the FCS setup since only one laser line was chosen to excite 
two fluorophores. In this thesis, the 514nm laser line from an argon ion laser 
(Spectra-Physics, Mountain View, CA) was chosen to excite two combinations 
of FPs, EGFP/mRFP and EYFP/mRFP. The dichroic mirror to reflect the laser 
beam was 525DRLP (Omega).  After the pinhole a second dichroic mirror, 
560DCLP (Omega), was placed to separate the fluorescence emissions of the 
two FPs. The short wavelength emission, i.e. emission of EGFP or EYFP, was 
reflected to the green detection channel. The longer wavelength emission, i.e. 
emission of mRFP, passed through the second dichroic mirror. Similarly, two 
bandpass filters, 545AF35 (Omega) and 615DF45 (Omega), were placed in 
front of the two APDs to further separate the fluorescence signals. The green 
and red fluorescence signals were cross-correlated by the same correlator 
Flex-02-12D (correlator.com). The ACF and CCF curves were fitted with the 
Levenberg-Marquardt algorithm using the same Igor Pro software 
(Wavemetrics Inc.).  
 
Fig. 2.4 (left) explains the basic principle of SW-FCCS. When two fluorescent 
molecules are interacting, they pass through the focal volume together along 
the same pathway (Fig. 2.4 A). Thus the two molecules give the same 
fluorescence fluctuation trace with time (Fig. 2.4 B). Consequently, the 
fluorescence signals in the two channels are correlated with each other, which 
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give a positive CCF curve as shown in Fig. 2.4 (C). The CCF curve is 
approaching the ACF curves.  On the other hand, if the two molecules do not 
bind, the intensity traces will be different and the CCF curve will be 
approaching a value of 1 on the Y axis, which is the uncorrelated background 
level (Figure 2.2 B). 
 
 
Fig. 2.4 SW-FCCS setup. (right) a single wavelength laser line is expanded 
and focused into the sample. After the pinhole a second dichroic mirror is 
placed to separate the two fluorescence emissions. The two APDs are 
connected to the same correlator for cross-correlation detection. (left) Figure 
illustrations of the principle of SW-FCCS. (A) Two interacting fluorescent 
molecules (one green and one red) diffuse together through the focal volume, 
which result in the two fluorescence signals show same intensity traces in (B). 
Thus a positive CCF curve is obtained (C). ACFg, autocorrelation function in 
green channel; ACFr, autocorrelation function in red channel.  
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Chapter 3  
Biological Sample Preparations  
 
Construction of plasmids encoding chimeras between FPs and ErbB 
receptors was the first step in the sample preparation. EGFP, enhanced 
yellow fluorescent protein (EYFP) and mRFP were attached to either C-
terminus or amino-terminus (N-terminus) of EGFR/ErbB2 by using standard 
recombinant techniques. A plasmid encoding mRFP-EGFR-EGFP was made 
as a positive control for SW-FCCS, and plasmids encoding FPs fused to a 
plasma membrane target (PMT) sequence at the FPs’ N-terminus were made 
as negative controls. The plasmids were then introduced into Chinese 
hamster ovary (CHO-K1) cells by either electroporation or Fugene 6 
transfection reagent. Cell treatments for confocal imaging and FCS/FCCS 
measurements, phosphorylation assays of EGFR chimera with FP, and 
fluorescence activated cell sorting (FACS) on ErbB2 on CHO-K1 cell surface 
are introduced separately in this chapter.      
 
3.1    FP-fusion Protein Constructions 
3.1.1 Construction of EGFR-FP fusions 
The C-terminus FP-fusion EGFR constructs, i.e. EGFR-EGFP and EGFP-
EYFP, were made by attaching EGFP and EYFP (Clontech, Mountain View, 
CA), respectively, to the C-terminus of the human EGFR. Each construct was 
created by the ligation of the following three fragments A, B, and C. Fragment 
A: the first 3.5 kb N-terminus portion of EGFR was excised from pNUT/EGFR 
(25) by sequential digestion with Kpn I and then with Bgl II, with a blunt-end 
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reaction carried out before the addition of Bgl II. Fragment B: the 0.8-kb 
fragment encoding the C-terminus of EGFR was amplified by polymerase 
chain reaction (PCR) with the following oligonucleotide primers encoding Bgl 
II and Age I sites (underlined), respectively; 5’-
CCAGCGAGATCTCCTCCATCC and 5’-
CCTCCGTACCGGTGCTCCAATAAATTCACTGC. The latter primer also 
encodes a proline residue at the stop codon indicated in italic. The resulting 
PCR product was then digested sequentially with Bgl II and Age I. Fragment 
C: pEGFP-N1 and pEYFP-N1 (Clontech) vectors were digested with Afe I and 
Age I. Fragments A and B were then ligated by using the Rapid DNA ligation 
kit (Roche Diagnostics, Singapore) to each of the pre-digested Fragment Cs. 
Fig 3.1 shows the procedure of the constructions of pEGFP-N1/EGFR-EGFP 
and pEYFP-N1/EGFR-EYFP. 
 
A plasmid encoding an EGFR-mRFP fusion protein was constructed by 
replacing the EGFP gene in the above EGFR-EGFP plasmid with mRFP. First 
mRFP was amplified from pRSETB/mRFP (167), kindly provided by Roger 
Tsien, University of California at San Diego, using the following primers with 
an Age I or Not I site (underlined), respectively: 5’-
GATCCACCGGTCGCCACCATGGCCTCCTCCGAGGACGTC, or 5’-
TTTTCCTTTTGCGGCCGCTTAGGCGCCGGTGGAGTG. The PCR product 
of mRFP was digested with Age I and Not I, and purified by gel extraction 
(MiniElute kit, Qiagen, Singapore). pEGFP-N1/EGFR-EGFP vector was 
digested with Age I and Not I to release the EGFP gene. The digested mRFP 
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fragment was then ligated into the digested vector to create pEGFP-
N1/EGFR-mRFP. 
 
 
Fig. 3.1 Constructions of EGFR-EGFP and EGFR-EYFP. 1., fragment A 
encoding the N-terminus portion of EGFR was excised out from pNUT vector 
by sequential digestion. 2., fragment B was amplified by PCR to remove the 
stop codon at the C-terminus of EGFR. 3., fragment A and B were cloned in 
tandem into the pre-digested Clontech vectors (fragment Cs) by ligation. 
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3.1.2 Construction of ErbB2-EGFP and ErbB2-mRFP 
The ErbB2-EGFP construct was created by fusing the ErbB2 and EGFP 
genes via an overlap PCR strategy. The ErbB2 gene contains a unique Age I 
site 0.8 kb upstream of the ErbB2 stop codon. This fragment was amplified 
from pcDNA/ErbB2 (kindly provided by Haihe Wang, Institute of Molecular 
and Cell Biology, Singapore), in which the full-length human ErbB2 cDNA was 
cloned between Nhe I and Not I sites of pcDNA 3.1/Zeo plasmid vector 
(Invitrogen), by PCR using a pair of primers, 5’-CTCCCGCATGGCCAGGGAC 
(primer A; this sequence resides upstream of a unique Afe I site of the ErbB2 
cDNA) and 5’-
CACCATCCCTCCACTCCCACTCCCTCCCACTGGCACGTCCAGACCCAGG
TAC (primer B). The primer B encodes a seven amino-acid residue linker that 
replaces the stop codon. The EGFP gene was also similarly amplified from 
pEGFP-N1 using a pair of primers, 5’-
GCCAGTGGGAGGGAGTGGGAGTGGAGGGATGGTGAGCAAGGGCGAGG
AGCTG (primer C) and 5’-GTCGCGGCCGCTTTACTTGTACAGCTCGTCC 
(primer D), which encodes Not I (underlined). Both primers B and C contain a 
21-base overlapping sequence encoding a 7-amino acid linker (underlined) 
between ErbB2 and EGFP. The two PCR products were mixed for overlap 
extension PCR with primers A and D, and the resulting product was digested 
with Afe I and Not I. The fragment was cloned into pcDNA/ErbB2 digested 
with the former two enzymes, resulting in pcDNA/ErbB2-EGFP. A plasmid 
encoding ErbB2-mRFP was similarly constructed from a PCR product 
amplified from pRSETB/mRFP using primers, 5’-
GCCAGTGGGAGGGAGTGGGAGTGGAGGGATGGCCTCCTCCGAGGACG
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TCATC and 5’-GTCGCGGCCGCTTAGGCGCCGGTGGAGTGGCG. Fig. 3.2 
shows the procedure of the construction of ErbB2-EGFP. 
 
 
Fig. 3.2 Construction of ErbB2-EGFP. The link between ErbB2 and EGFP is 
realized by overlap PCR through a 21bp linker.  
 
3.1.3 Construction of mRFP-EGFR and mRFP-EGFR-EGFP  
To make the N-terminal fusion construct of EGFR with FP, an Xho I restriction 
site was created just after the signal peptide cleavage site of EGFR (at 72 bp 
from the N-terminus of EGFR gene) by site-directed mutagenesis using a 
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QuickChange XL kit (Stratagene, La Jolla, CA), pNUT/EGFR as a template, 
and the following mutagenic primers: 5’-
CCGGCGAGTCGGGCTCTCGAGGAAAAGAAAGTTTGC and 5’-
TTGGCAAACTTTCTTTTCCTCGAGAGCCCGACT, in which mutation sites 
(at 75 bp from the N-terminus of EGFR gene) are underlined. To construct an 
expression plasmid encoding mRFP-EGFR, the mRFP gene was amplified by 
PCR from pRSETB/mRFP with the following primers: 5’-
GCGCGCCTCGAGATGGCCTCCTCCGAGGACGTC and 5’-
GCGCGCCTCGAGACTCCCACTCCCTCCGGATCCGGCGCCGGTGGAGTG
GCG, in which Xho I sites are underlined. The resulting PCR product was 
digested with Xho I. The EGFR gene with the created Xho I site (located in 
the pNUT/EGFR vector) was also digested with XhoI. In order to prevent self-
ligation, the digested pNUT/EGFR vector was treated with shrimp alkaline 
phosphatase (SAP) (Roche) at 37°C for 1 h. The reaction was stopped by 
incubating at 65°C for 15 min. Subsequently, the digested mRFP gene was 
cloned into the Xho I site of the EGFR gene of SAP-treated pNUT/EGFR.  
 
The mRFP-EGFR-EGFP construct was made by inserting the EGFP gene 
into the 3’ end of the EGFR gene of pNUT/mRFP-EGFR. This was 
accomplished by a straightforward sub-cloning of EGFP (from the pEGFP-
N1/EGFR-EGFP construct) into the N-terminus construct pNUT/mRFP-EGFR. 
The pNUT/mRFP-EGFR contains a unique Sma I (located 2.9 kb upstream of 
the EGFR stop codon) and a unique Age I site (located 0.76 kb downstream 
of the same stop codon), while the C-terminus pEGFP-N1/EGFR-EGFP 
construct contains a unique Sma I (located at the same site in the EGFR gene) 
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and Not I site (located immediately after the EGFP stop codon). The 
pNUT/mRFP-EGFR and pEGFP-N1/EGFR-EGFP vectors were first digested 
with Age I and Not I, respectively. The sticky ends of the digested fragments 
were blunted by treatment with T4 DNA polymerase (Promega, Singapore), 
and purified by ethanol precipitation. Both the vectors were then digested with 
SmaI and run on agarose gel electrophoresis for purification. The 6.8kb 
fragment from the pNUT/mRFP-EGFR and the 3.6kb fragment from the 
pEGFP-N1/EGFR-EGFP were excised and purified using the MiniElute gel 
purification kit (Qiagen). The purified fragments were subsequently ligated to 
yield the full-length EGFR gene with the respective N- and C-terminal fusions. 
Fig. 3.3 shows the procedure of the construction of mRFP-EGFR-EGFP. 
 
3.1.4 Construction of PMT-FPs 
The N-terminal 15 amino acids of the X-linked retinitis pigmentosa protein 
RP2 has been reported to be sufficient for plasma membrane localization of 
proteins (168). This 15 amino acids peptide corresponds to a 45-bp nucleotide: 
5’ ATGGGCTGCTTCTTCAGCAAGCGGCGGAAGGCCGACAAGGAGAGC 3’.  
A two-step PCR was performed to fuse the PMT sequence to the N-terminus 
of each FP gene. The EGFP gene was amplified from pEGFP-N1 by PCR 
using a pair of primers, 5’-
AGCAAGCGGCGGAAGGCCGACAAGGAGAGCATGGTGAGCAAGGGC 
(PMS1) and 5’-TTTTCCTTTTGCGGCCGCTTACTTGTACAGCTCGTC 
(PMS5). PMS1 encodes part of the PMT sequence (in italic), and PMS5 
encodes a Not I site (underlined). The resulting PCR product was then used 
as a template for the second round of PCR with primers, 5’-
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GATCCACCGGTATGGGCTGCTTCTTCAGCAAGCGGCGGAAG (PMS2), 
which encodes an Age I site (underlined) and the remaining sequence of PMT 
(in italic), and PMS5. The resulting PCR product was then doubly digested 
with Age I and Not I, and was cloned into pEGFP-N1 from which the FP gene 
was removed by digesting with Age I and Not I. Similarly, plasmids encoding 
PMT-EYFP was also made using the same primers as EYFP gene has the 
same N- and C-terminal sequences as that of EGFP in the Clontech vectors.  
 
      
Fig. 3.3 Construction of mRFP-EGFR-EGFP. This construct was made by 
joining the 5’ mRFP-EGFR fragment of pNUT/mRFP-EGFR and 3’EGFR-
EGFP fragment of pEGFP-N1/EGFR-GFP through a Sma I site on the EGFR 
gene on both plasmids. 
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For the construction of PMT-mRFP, mRFP gene was first amplified from 
pRSETB/mRFP using the following primers: 5’- 
AGCAAGCGGCGGAAAGGCCGACAAGGAGAGCATGGCCTCCTCCGAGGA
CGTC (TMRN2) and 5’- 
TTTTCCTTTTGCGGCCGCTTAGGCGCCGGTGGAGTGGCG (TMRC1). 
TMRN2 encodes part of the PMT sequence (in italic), and TMRC1 encodes a 
Not I site (underlined). The resulting PCR product was then used as a 
template for the second round of PCR with primers, 5’-
GATCCACCGGTATGGGCTGCTTCTTCAGCAAGCGGCGGAAGGCC 
(TMRN1), which encodes an Age I site (underlined) and the remaining 
sequence of PMT (in italic),  and TMRC1. The resulting PCR product was 
then doubly digested with Age I and Not I, and was cloned into pEGFP-N1 
from which the FP gene was removed by digesting with Age I and Not I.  
 
Besides, another negative control for SW-FCCS was the cytosolic GFP/mRFP 
pair, in which the mRFP construct was simply amplified from pRSETB/mRFP 
vector and inserted into pEGFP-N1 vector (Clontech) by replacing the EGFP 
gene through Age I and Not I sites.  
 
3.1.5 Summary 
All the above mentioned constructs were confirmed by automated DNA 
sequencing. Fig. 3.4 summaries the FP-fusion constructs that were used in 
the study of the EGFR/ErbB2 dimerization. The fusion constructs are 
physiologically wild type in terms of phosphorylation and endocytosis, as we 
will show later in Chapter 6. 
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Fig. 3.4 A schematic overview of FP-fusion EGFR/ErbB2 constructs together 
with the PMT-FPs. ECD, extracellular domain; TMD, transmembrane domain; 
ICD, intracellular domain.    
 
 
Fig. 3.5 A schematic representation of FP-fusion Cdc42 and its effectors. 
EGFP was fused to the N-terminus of the active and inactive forms of Cdc42, 
and mRFP was fused to its known effectors NWASP, IRSp53 and Toca1 
through 2-4 amino acid linkers. The shadow areas signify the interactive 
domains of Cdc42 and the effectors. ED, effector domain; WH1, WASP 
homology domain1; WH2, WASP homology domain 2; RCB, Rac binding; 
IMD, IRSp53-MIM homology domain. 
 
Similarly, our collaborators in Dr Sohail Ahmed’s lab made the fusion 
constructs of Cdc42 and the effectors.  EGFP was fused to the Cdc42V12 and 
Cdc42N17, and mRFP was fused to some of its effector proteins through 
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recombinant techniques. Fig. 3.5 gives the schematic drawing of these fusion 
constructs. 
 
3.2 Sample preparations for imaging, FCS/FCCS and   
phosphorylation assay  
3.2.1 Cell culture and transfection 
In this thesis, most of the FCS/FCCS measurements were done on CHO cells. 
CHO-K1 cells purchased from ATCC (Manassas, VA) were cultivated in 
Ham’s F12 medium (with Kaighn’s modification) supplemented with 2 mM L-
glutamine, 1.5 g/L sodium bicarbonate, 50 U/ml penicillin G, 50 μg/ml 
streptomycin and 10% fetal bovine serum (FBS) at 370C in 5% (v/v) CO2 
humidified atmosphere. Two methods were used to introduce plasmids DNA 
into CHO cells, electroporation and the Fugene 6 transfection kit (Roche 
Diagnostics, Singapore).  
 
Electroporation was applied to introduce FP-fusion ErbB plasmids into CHO 
cells. ~90% confluent cells in a flask were washed once with 1 × phosphate 
buffered saline (PBS), trypsinized with 0.25% trypsin-0.03% EDTA solution for 
5 min at 37oC, and then resuspended in culture medium. ~1 ×106 cells were 
precipitated by centrifugation, and resuspended in culture medium in an 
electroporation cuvette, 2 mm wide (Bio-Rad, Hercules, CA). The amount of 
DNA that was used for single transfection was 5 μg for one reaction. For the 
co-expression of two FP-fusion constructs, the amount of each plasmid was 5 
μg, and total 10 μg for one electroporation reaction.  After mixing the cells with 
DNA, the cuvette was chilled on ice for 10 min. GenePulser Xcell (Bio-Rad) 
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was used for electroporation by following the manufacturer’s pre-programmed 
protocol for CHO cells. After electroporation, cells were left for 10 min at room 
temperature (RT), and~50,000 cells/well were seeded in wells of a six-well 
plate containing prewashed cover glasses (30 mm in diameter; Lakeside, 
Monee, IL). Two days after transfection, cells were washed once with 1 × PBS, 
and were further cultivated in F12K medium containing 0.1% FBS, 50 U/ml 
penicillin G, and 50 μg/ml streptomycin for 4-8 h.  
 
A Fugene 6 transfection kit was used for the transfection of plasmids of FP-
fusion Cdc42 and effectors. Cells were seeded in 6-well plates containing the 
30 mm cover glasses at 1 × 105 cells/well one day before transfection. On the 
day of transfection, 3 μl Fugene 6 transfection reagent was added to ~95 μl 
serum-free medium and incubated for 5 min at RT. A total amount of 2 μg 
DNA (~2 μl) was added to the prediluted Fugene 6 reagent, mixed and 
incubated at RT for 15 min. The growth medium in each well of the 6-well 
plate was replaced with 900 μl fresh medium, and then the mixed 
DNA/transfection reagent was added. The plate was put back to incubators 
for overnight incubation. On the next day after transfection, the medium was 
replaced with fresh medium. Cell measurements on microscopes were carried 
out on the same day, i.e. 24 h after transfection. This time period was shorter 
than that of the culture of the ErbB plasmids transfected cells, as the 
expression of FP-fusion Cdc42 and effectors were faster than the expression 
of FP-fusion ErbB receptors. 
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At the time of observation, cells were treated under different conditions 
according to different experimental targets.  The following sections introduce 
these experimental conditions separately. 
  
3.2.2 Imaging and FCS/FCCS on FP-fusion proteins in live cells 
To observe the expression of FP-fusion proteins in live cells under a confocal 
microscope, cells were washed several times with 1 × PBS and covered with 
D-MEM /F-12K medium lacking of phenol red (Gibco, Invitrogen, Singapore) 
in a POC mini-chamber (Carl Zeiss, Singapore). Confocal imaging of the FP-
fusion proteins in live cells was normally done at RT. One exception was the 
observation of the internalization of the FP-fusion EGFRs after EGF 
stimulation. This experiment was done at 37°C by using a heating stage with 
a tempcontrol 37-2 digital (Zeiss). This is because at 37°C internalization of 
the receptors is more efficient than that at lower temperature (169, 170). The 
final concentration of ligand, i.e. EGF, was kept at 100 ng/ml during the 
imaging observation of receptor internalization (171). 
 
To minimize fluorescence background during FCS/FCCS measurements on 
FP-fusion proteins, cells were washed thoroughly with 1 × PBS and covered 
with 1ml 1 × PBS in the POC mini-chamber (Zeiss). FCS/FCCS 
measurements were done at RT for two reasons. First, fluorescent probes are 
more stable at RT and give better fluorescent signals than at higher 
temperature (89). Second, the biological live cell system is more stable at RT, 
e.g., there is less perturbation on membrane at RT (89). To avoid fast 
internalization of the ErbB receptors after EGF activation during SW-FCCS 
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observation, cells were incubated with endocytosis inhibitors half an hour 
before adding EGF. The final concentration of the inhibitors was NaN3 
(Sigma), 10 mM; NaF (Sigma), 2 mM; 2-Deoxy-D-Glucose (Sigma), 5 mM, 
respectively. Similarly, the final concentration of EGF was kept at 100 ng/ml 
during FCS/FCCS observation of ErbB receptor activation.  
 
           3.2.3   Phosphorylation assays of ErbB receptor chimera with FP 
To analyze autophosphorylation activity of the chimeric EGFR constructs, the 
expression plasmid vector DNAs, 2-8 μg each, were introduced into COS-7 
cells (ATCC), ~1 × 106 cells per tube, by using a Nucleofector II (amaxa 
GmbH, Germany) under pre-set conditions by the manufacturer.  After 
cultivating the transfected cells for two days in a culture dish (6 cm in 
diameter), cells (~3 × 106) were starved in the absence of serum for 24 h, and 
were then stimulated with 100 ng/ml (a final concentration) of EGF on ice for 
30 min (25). After washing three times with ice-cold 1 × PBS, the cells were 
solubilized with 1 × Laemmli sample buffer (100 μl; Bio-Rad) supplemented 
with 1.0 mM Na3VO4 and 5% mercaptoethanol, and were heat denatured for 
10 min at 95oC. Samples were stored at -86oC until use. An aliquot, 2-40 μl 
each per lane, of the samples was electrophoretically separated with a 7% 
SDS-polyacrylamide gel, and blotted onto a Hybond-P PVDF membrane (pore 
size, 0.45 μm; GE Healthcare, Little Chalfont, UK). After blocking the 
membrane with 5% skimmed milk in TBS buffer (20 mM Tris-Cl, pH 7.4, 150 
mM NaCl, 0.1% Tween-20), EGFR chimera and its phosphorylated form were 
stained with anti-EGFR antibody (Ab-12; Lab Vision, Fremont, CA), and 
followed by incubating with a secondary antibody, sheep anti-mouse IgG 
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conjugated with horseradish peroxidase. For the detection of a 
phosphorylated form of the receptors, alternatively, the membrane was 
blocked with a mixture of Blocking One-P (nakalai tesque, Kyoto, Japan), 2% 
ECL Blocking reagent (GE Healthcare) and 50 mM NaF, and was subjected 
for binding with anti-pTyr (PY20) antibody (sc-508; Santa Cruz Biotech., 
Santa Cruz, CA) as a primary antibody and then with a secondary antibody as 
described above. The proteins were visualized by treating the membrane with 
an ECL Western blotting detection kit (GE Healthcare), and were analyzed by 
using a Fujifilm Luminescent Image Analyzer (LAS-3000; Tokyo, Japan).  
 
3.3   Sample preparation for the determination of ErbB2 expression 
level in CHO-K1 cells by FACS 
CHO-K1 cells do not express endogenous EGFR but express background 
level of ErbB2 (172). To quantitatively determine ErbB2 expression level in 
CHO-K1 cells, quantitative flow cytometry was carried out on a FACS Aria 
(BD) machine by following the QIFIKIT (DakoCytomation, Denmark) protocol 
(173).   CHO-K1 cells were grown in 75 cm2 flask up to 90% confluency in the 
same growth medium as introduced before, and serum starved overnight 
(media without FBS and antibiotics). The next day cells were washed two 
times with 1x PBS, trypsinised, and immediately resuspended with 10 ml F-12 
nutrient mixture (Kaighn’s modification) media without FBS and antibiotics. 
Cells were counted and adjusted to 2 × 105 cells / 100 µl volume in the same 
medium, and 100 μl each of cells were put into four test tubes. Tube 1 was 
kept as control and kept without any antibody treatment except PBS-bovine 
serum albumin (BSA) (0.5% BSA in 1× PBS, pH 7.4) treatment. Cells in Tube 
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2 were treated with 20 µl primary antibody, i.e. anti-c-ErbB2/c-Neu (AB-4) 
mouse mAb (Calbiochem, Singapore) at a 100 µg/ml concentration for 30 min 
at RT. After the treatment 3.0 ml of 1 × PBS-BSA was added and cells were 
centrifuged down at 400 × g for 10 min at RT. The supernatant was removed 
and cells were resuspended in 0.5 ml of 1 × PBS-BSA. This was used as an 
additional control. Tube 3 was treated with 100 µl of the kit supplied FITC-
conjugated goat anti-mouse antibody (diluted 1:50 in 1 x PBS-BSA buffer) for 
30 min at RT in the dark. 3.0 ml of 1 × PBS-BSA buffer was added and cells 
were centrifuged down at 400 × g for 10 min at RT .The supernatant was 
removed and cells were resuspended in 0.5 ml of 1 × PBS-BSA. This was 
used as an additional control for non-specific binding of the provided 
antibodies. Cells in Tube 4 were treated with 20 µl of 100 µg/ml anti-c-
ErbB2/c-Neu (AB-4) mouse mAb for 30 min at RT. 3.0 ml of 1 × PBS-BSA 
buffer was added and cells were centrifuged down at 400 × g for 10 min at 
RT .The supernatant was removed. Cell pellets were resuspended in 50 µl of 
1 × PBS-BSA and were further incubated with the secondary antibody, 100 µl 
of the kit supplied FITC-conjugated goat anti-mouse antibody (diluted 1:50 in 
1 × PBS-BSA) for 30 min at RT in the dark. 3.0 ml of 1 × PBS-BSA (0.5% BSA 
in1 × PBS) buffer was added and cells were centrifuged down at 400 × g for 
10 min at RT. The supernatant was removed and cells were redissolved in 0.5 
ml of 1 × PBS-BSA. This was used to measure the number of ErbB2 
molecules on the membrane of CHO-K1 cells.  
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Chapter 4  
FCS Study on Fluorescent Proteins and Fluorescent 
Protein-fusion Proteins in Live Cells 
 
FCS was first performed to characterize the photodynamic properties of 
EGFP, which helps in choosing a proper fitting model to fit the raw data points 
of FCS on FPs in live cells. FCS measurements on EGFP in the cytoplasm of 
CHO cells were compared to the report on the photodynamic properties of 
EGFP in solution (86), so that the photodynamic characteristics of EGFP in 
cells were determined. Subsequently, the photophysical properties of fusion 
EGFPs that locate on the cell membrane, i.e. PMT-EGFP and EGFR-EGFP, 
were investigated by FCS and the results were compared to that of the 
cytoplasmic EGFP. Similarly, the photocharacteristics of EYFP, mRFP and 
their fusion proteins in CHO cells were studied by FCS. The photodynamic 
processes of FPs and fusion FPs can be fitted with two exponential decay 
terms; one for the intersystem transition between singlet-triplet states, and the 
other for the additional photodynamic processes with longer decay time-
ranges. Besides, FCS was also applied to study the expression level of 
endogenous ErbB2 on CHO cell surfaces, and the result was compared with 
the result from FACS experiment.  
 
4.1    FCS on EGFP and EGFP-fusion proteins in live cells 
4.1.1 Characterization of the photodynamic properties of EGFP in 
CHO cells 
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By using FCS, Widengren et al. thoroughly studied the photodynamic 
properties of EGFP in solution (86). EGFP exhibits a unique rotational 
correlation time of 20 ns, relaxation times of photodynamic processes ranging 
from submicrosecond to several hundred microseconds, and a translational 
diffusion time diffτ in the millisecond time-range (86). The photodynamic 
processes include intersystem crossing to the triplet state at submicrosecond 
time-range as well as additional photodynamic processes such as photo-
induced isomerization with characteristic times ranging from 10 μs to 500 μs. 
Similar photodynamic properties of EGFP expressed in the cytoplasm of CHO 
cells were observed (Fig. 4.1).  
 
The raw data points of FCS on EGFP expressed in the cytoplasm of CHO 
cells were fitted with the three-dimensional (3D) diffusion and two-exponential 
decay model (Eq. (2.8)). EGFP in the cytoplasm of cells exhibits a 
translational diffusion time in the millisecond (ms) time-range (Fig. 4.1 B), 
which is similar to the diffτ measured in solution (86). Two exponential decay 
terms were in the fitting model; one for the triplet state relaxation decay and 
one for the slower photodynamic processes such as photo-induced 
isomerization (112, 121, 174). Fig. 4.1 (C) shows that similar decays were 
observed in the ACFs of a series of cells expressing different concentrations 
of EGFP, which indicates that EGFP exhibits identical photodynamic 
characteristics, as well as an identical mobility ( diffτ  at ~1 ms) in the 
cytoplasm of cells.  The fraction of molecules being in the photodynamic 
processes increases at higher excitation intensities (Fig. 4.1 D). The 
additional photodynamic processes can be considered as transitions of  
 66
 
Fig. 4.1 Characterization of the photodynamic properties of EGFP in CHO 
cells.  (A) (left) Confocal image of EGFP expressed in CHO cells. Bar, 10 μm. 
(middle) Z-axial scan of a cell expressing EGFP before FCS measurements. 
Similar fluorescence intensity was observed all through the cell, as EGFP 
locates all through the cytoplasm of cells. (right) Fluorescence intensity trace 
during a FCS measurement of EGFP in CHO cells. (B) A representative ACF 
curve of EGFP in the cytoplasm of CHO cells. The ACF curve was fitted with 
the 3D translational diffusion of one species with two exponential decays 
model (Eq. (2.8)). The exponential decay of triplet state relaxation was fitted 
separately from the decay of other additional photodynamic processes so that 
two exponential decay terms were included in the fitting model. (C) ACF 
curves of cells expressing different levels of EGFP. All the curves were fitted 
with the same model as the one in (B), which reveals that EGFP exhibits 
identical photophysical characteristics in the cytoplasm of cells. (D) The 
fraction of molecules in the photodynamic processes increases with the 
increase of excitation laser power. (E) Characterization of the translational 
diffusion time of EGFP in CHO cells. The translational diffusion time 
decreases with the increase of excitation laser power, possibly due to the 
photobleaching or photodegradation of EGFP molecules at high laser 
intensities during their dwelling in the focal volume.  
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fluorophores into nonluminescent states which are similar to the singlet-triplet 
state transitions. Widengren et al. thoroughly studied triplet states of 
fluorophores by FCS and reported that the triplet populations are increased at 
higher excitation laser intensities (174). The additional photodynamic 
transitions may undergo similar kinetics so that increased populations of 
molecules in the photodynamic processes are observed. On the other hand, 
the translational diffusion time of EGFP in solution decreases with the 
increase of excitation laser power (86), possibly due to a higher rate of 
photobleaching or photodegradation of EGFP at higher excitation laser power. 
A similar phenomenon was observed for EGFP expressed in CHO cells (Fig. 
4.1 E). The average diffusion time decreases with the increase of excitation 
laser power, which confirms that the decay at ~1ms arises from translational 
diffusion of EGFP.  
 
In summary, the characteristic parameters of photodynamic processes and 
translational diffusion are relatively stable at an excitation laser power 
between 40-50 μW. The fluorescence intensity trace in Fig. 4.1 A (right) 
shows that at such excitation laser power the photobleaching of EGFP can 
not be detected. Therefore, most of our FCS/SW-FCCS measurements were 
carried out using excitation laser power at ~40 μW unless otherwise specified. 
 
4.1.2 Characteristics of the photophysical dynamics of PMT-EGFP 
and EGFR-EGFP in CHO cells  
In Chapter 3 we introduced the construction of a series of PMT-FPs, in which 
a 15aa peptide sequence was fused to the N-terminus of FPs to lead the FPs 
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to the plasma membrane of cells (168). Fig. 4.2 A (left) shows the confocal 
image of PMT-EGFP expressed in CHO cells. The image shows clear 
fluorescence at the periphery of the cell, which indicates that EGFP 
translocated to the cell membrane. A z-axial scan was done through the cell 
before FCS measurements (Fig. 4.2 A (middle and left)). Two distinctive 
peaks with high fluorescence intensity were observed and low fluorescence 
intensity between the two peaks was observed, as the fluorescence was 
located on the bottom and top membranes but not in the cytoplasm of the cell. 
For FCS/FCCS measurements on membrane proteins, we chose to focus on 
the center part of the top membrane for several reasons. First, the bottom 
membrane of cells is close to the cover glass surface, light reflection of the 
cover glass may increase the background noise. Second, due to membrane-
glass surface interactions, the mobility of proteins might be more complex 
than on the top membrane. Besides, as the center part of the top membrane 
is relatively more flat than other parts according to the morphology of cells, 
focusing on the center part of the top membrane may give a relatively more 
stable observation of protein mobility (175).   
 
Fig. 4.2 B shows a typical ACF curve of PMT-EGFP in CHO cells. The raw 
data points were fitted with the 2D translational diffusion of one species with 
two exponential decays model (Eq. (2.8)), as FCS focuses on the relatively 
flat top membrane which can be assumed as an XY surface. The 
characteristics of photodynamic processes including triplet state relaxation of 
PMT-EGFP are similar to that of the free EGFP in the cytoplasm of cells, i.e. 
with time-ranges from over ten microseconds to hundred microseconds.       
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Fig. 4.2 Image and ACFs of PMT-EGFP expressed in CHO cells. (A) (left) 
Confocal image of a cell expressing PMT-EGFP. (middle and right) A Z-scan 
of a cell expressing PMT-EGFP. Two distinctive fluorescence intensity peaks 
were observed due to the location of PMT-EGFP on both bottom and top 
membranes of the cell. (B) A representative ACF curve of PMT-EGFP in CHO 
cells. Characteristics of the photodynamic processes including triplet state 
relaxation of PMT-EGFP were similar to that of the cytosolic EGFP, while the 
translational diffusion of PMT-EGFP was much slower due to the high 
viscosity of membrane lipid environment. (C) A series of ACFs from cells 
expressing different levels of PMT-EGFP. The fluctuations of the 
characteristic parameters of PMT-EGFP were larger than that of cytosolic 
EGFP, possibly due to the heterogeneity or thermal fluctuations of cell 
membranes.  
 
However, the translational diffusion time of PMT-EGFP was much longer than 
that of cytoplasmic EGFP (over 10 ms on membrane vs. ~1 ms in the 
cytoplasm). This is expected as the viscosity of the lipid environment on the 
plasma membrane is higher than the viscosity in the cytoplasm (176).  
Similarly, a series of ACFs from cells expressing different levels of PMT-
EGFP are shown in Fig. 4.2 C. The curves exhibit similar decays as the 
membrane environment determines the mobility of PMT-EGFP. However, the 
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fluctuations of the characteristic parameters of PMT-EGFP were larger than 
that of EGFP in the cytoplasm, which may arise from the heterogeneity or 
thermal fluctuations of cell membranes (95).  
 
FCS measurements were further carried out on cells expressing EGFR-EGFP. 
Fig. 4.3 shows the image of a cell expressing EGFR-EGFP and the ACFs of 
EGFR-EGFP in CHO cells. Similarly, the fluorescence was shown on the 
edge of the cell (Fig. 4.3 A left), as EGFR translocates to the plasma 
membrane of cells; and two fluorescence intensity peaks were observed from 
z-axial scan through the cell (Fig. 4.3 A middle), which indicates the 
fluorescence is distributed on the membrane of the cell. The characteristics of 
the ACFs of EGFR-EGFP are similar to that of PMT-EGFPs, which were fitted 
with the 2D translational diffusion of one species with two exponential decays 
model (Fig. 4.3 B and C). Still, the fluctuations of the characteristic 
parameters from ACFs were larger than that of the EGFP in the cytoplasm, 
which may arise from the heterogeneity of cell membranes or membrane 
fluctuations. In addition, the large fusion receptor may also affect the 
photodynamics of EGFP since EGFP was fused to the C-terminus of the 
receptor.  
 
In summary, this section discussed the photodynamic characteristics of EGFP 
and two EGFP-fusion proteins that locate to the cell membrane. The 
photodynamic characteristics of PMT-EGFP and EGFR-EGFP are similar to 
that of EGFP in the cytoplasm, i.e. triplet state relaxation time at microsecond 
time-range and additional photodynamic processes with time-ranges from 
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over ten microseconds to several hundred microseconds. The major 
difference between membrane-located EGFPs (including PMT-EGFP and 
EGFR-EGFP) and cytoplasmic EGFP is that the translational diffusion time of 
membrane EGFPs is over ten times longer than that of the cytoplasmic EGFP, 
 
 
Fig. 4.3 Image and ACFs of EGFR-EGFP expressed in CHO cells. (A) (left) A 
confocal image of a cell expressing EGFR-EGFP. Bar, 10μm. (middle) a z-
scan of a cell expressing EGFR-EGFP. Two distinctive fluorescence intensity 
peaks were observed due to the location of EGFR-EGFP on both bottom and 
top membranes of CHO cells. (right) Intensity trace during FCS measurement. 
The fluorescence fluctuations are more irregular compared to the fluctuations 
in the cytoplasm due to the heterogeneity or fluctuations of membrane. (B) A 
representative ACF curve of EGFR-EGFP in CHO cells. Characteristics of the 
photodynamic processes including triplet state relaxation of EGFR-EGFP 
were similar to that of EGFP in the cytoplasm, while the translational diffusion 
time of EGFR-EGFP was at least a factor of magnitude longer than that of the 
cytoplasmic EGFP, due to the high viscosity of membrane lipid environment. 
(C) A series of ACFs from cells expressing different levels of EGFR-EGFP. 
The fluctuations of the characteristic parameters of EGFR-EGFP were larger 
than that of the cytoplasmic EGFP, possibly due to the heterogeneity of the 
cell membranes, thermal dynamic fluctuations of the membrane, or the 
activities of the fusion ErbB receptors. 
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due to the high viscosity of lipid membrane environment. In addition, ACFs of 
membrane fusion EGFPs are not as homogenous as ACFs of cytoplasmic 
EGFP. Possible reasons could be the heterogeneity of the cell membrane or 
membrane fluctuations. In addition, the activities of the receptor might also 
affect the photophysical behavior of EGFP which is fused at the C-terminus of 
the receptor. For example, the flexible C-terminus of EGFR may rotate or 
undergo different conformational changes, and the C-terminus-linked EGFP 
follows the changes which could be revealed by its fluorescence fluctuations. 
A summary of the photodynamic parameters of the FPs and FP-fusion 
proteins will be given in the next section after the introduction of FCS 
measurements on EYFP and mRFP. 
 
4.2    FCS on EYFP, mRFP and their fusion proteins in live cells 
FCS measurements were carried out on CHO cells expressing EYFP, mRFP 
and their membrane-located fusion proteins. Fig. 4.4 A shows some 
representative confocal images of these proteins expressed in CHO cells, 
(from left to right) EYFP, PMT-EYFP, mRFP and EGFR-mRFP. Native EYFP 
and mRFP were distributed in the cytoplasm of the cells. After being fused 
with the PMT peptide or the membrane receptor EGFR, the two FPs were 
lead to the plasma membrane of cells, as shown by the PMT-EYFP and 
EGFR-mRFP images in Fig. 4.4 A.  
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Fig. 4.4 Images and ACFs of EYFP, mRFP and their fusion proteins on the 
cell membrane. (A) (from left to right) confocal images of EYFP, PMT-EYFP, 
mRFP and EGFR-mRFP in CHO cells. (B) ACFs of cytoplasmic EYFP (left) 
and mRFP (right). The ACF of mRFP shows a larger fraction of photodynamic 
processes than that of the EYFP. (C) ACFs of PMT-EYFP (left) and PMT-
mRFP (right). (D) ACFs of EGFR-EYFP and EGFR-mRFP. Both the PMT-FPs 
(C) and EGFR-FPs (D) showed longer translational diffusion time than that of 
the cytoplasmic FPs (B). The translation diffusion time of the two fusion 
EYFPs is slightly faster that of the two fusion mRFPs, which may be resulted 
from the photobleaching or photodegradations of EYFP.  
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Fig. 4.4 (B) compares the ACFs of EYFP and mRFP in the cytoplasm. Similar 
to the ACF of EGFP, both ACFs of EYFP and mRFP could be fitted with one 
triplet state term, one additional photodynamic process term and one 
translational diffusion term. The ACF of mRFP exhibited a larger fraction of 
photodynamic processes compared to that of EGFP and EYFP (parameters 
were listed in Table 4.1), which may be due to the transition into the non-
fluorescent dark states of mRFP (177).  This is also in agreement with the fact 
that mRFP exhibits a low fluorescence quantum yield (166). Similar to EGFP 
and its membrane fusion proteins, ACFs of fusion EYFP and mRFP show 
longer translational diffusion times than that of the cytoplasmic EYFP and 
mRFP (Fig. 4.4 C and D). However, the translational diffusion times of PMT-
EYFP and EGFR-EYFP were slightly faster than that of the other two FPs’ 
membrane fusion proteins (Table 4.1). This may be due to a faster 
photobleaching rate of the fusion EYFPs on cell membranes.  
 
Table 4.1 summaries the characteristic parameters (± standard deviation (SD)) 
of the three FPs and their fusion proteins investigated by FCS. The three 
cytoplasmic FPs showed a similar translational diffusion time as they all 
located in the cytoplasm of cells. The two groups of membrane fusion proteins 
both a showed longer translational diffusion time than that of the cytoplasmic 
FPs, due to the high viscosity lipid environment on cell membrane.  dynaτ  and 
dynaF  (fraction of the photodynamic processes) both changed after the FPs 
were fused to PMT and EGFR, indicating that the photodynamic properties of 
the FPs are affected by the different subcellular locations of the FPs.  The 
molecular brightness (cps) of the fusion FPs are also different from the native 
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FPs, possibly due to the different autofluorescence background at different 
subcellular locations, or the physiological activities of the receptor (EGFR-
FPs). The cps of EGFR-EGFP is much higher than that of the cytoplasmic 
EGFP and PMT-EGFP, which may indicate that the receptor exists in different 
forms on the membrane. Comparison between PMT-mRFP and EGFR-mRFP 
also indicates that the receptor may exist in higher-order tertiary structures 
(note these two data sets should not be compared with that of the cytoplasmic 
mRFP as the two fusion FPs were measured using a different excitation laser 
line). However, the cps of FPs could be affected by factors like 
autofluorescence background (different cells may exhibit different 
backgrounds) and different focusing positions (the focus point may not be 
exactly at the location of FPs). Thus cps alone is not enough to tell whether 
the receptor exists in monomeric or dimeric forms on native cell membranes.  
 
Table 4.1 Characteristic parameters of EGFP, EYFP, mRFP and their fusion 
proteins in CHO cells investigated by FCS 
 
Protein name 
diffτ  
(ms) 
dynaτ  
(μs) 
dynaF  
(%) 
cps 
(kHz) 
excitation 
λ (nm) 
excitation
intensity 
(μW) 
EGFP 1.0±0.3 91.9±77.9 24.1±8.0 7.2±4.1 488 50 
EYFP 0.9±0.2 29.4±8.2 49.6±4.4 6.9±2.6 514 50 
mRFP 0.9±0.1 85.6±7.0 58.7±1.2 3.0±0.7 530 50 
PMT-EGFP 14.1±4.3 326.8±78.5 36.6±4.1 6.1±3.9 488 50 
PMT-EYFP 7.6±2.5 58.9±43.9 42.9±7.0 5.3±3.3 514 50 
PMT-mRFP 60.1±14.4 277.8±50.9 43.8±3.0 1.1±0.1 514 50 
EGFR-EGFP 30.2±12.4 470.3±73.3 28.8±14.5 14.3±15.9 488 50 
EGFR-EYFP 10.3±4.6 158.6±175.5 42.7±6.1 8.0±6.3 514 50 
EGFR-mRFP 47.5±20.4 136.4±32.6 56.2±2.7 2.0±0.5 514 50 
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4.3    Quantitation of the expression level of endogenous ErbB2 in 
CHO cells 
Quantitation of the local concentration of fluorescent particles is one basic 
function of FCS (Eq. (2.9)). However, this application is limited in live cells due 
to the complexity of live cell systems. Fluorescence activated cell sorting is a 
standard quantitative fluorescence flow cytometry method to measure 
membrane protein expression levels (173). In this thesis, our target was to 
study the interactions between ErbB receptors. As measurements were 
carried out in CHO cells, which is known to express background level of 
ErbB2 (172), we set out to quantify endogenous ErbB2 expression level in 
order to estimate its competition effect in the interactions between FP-fusion 
ErbB receptors. In addition, FCS measurements were carried out on CHO 
cells treated with the same primary and secondary antibodies for comparison. 
CHO cells were incubated with the primary anti-c-ErbB2/c-Neu (AB-4) mouse 
mAb (Calbiochem) and secondary FITC-conjugated goat anti-mouse antibody 
provided by the QIFIKIT (DakoCytomation) for four hours. At the time of 
observation, the cells were washed thoroughly with 1×PBS to remove the 
unbound antibodies and covered by 1×PBS during FCS measurements.  
 
QIFIKIT (Dako) is a standard protocol to quantitatively determine protein 
expression levels on cell surface by using an indirect immunofluorescence 
assay (178). A calibration curve was obtained by plotting the fluorescence 
intensity of the individual bead populations against the number of mAb 
molecules on the beads (Fig. 4.5 A).  Five populations of beads bearing 
different numbers of mAb molecules were incubated with the provided 
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secondary antibody goat anti-mouse immunoglobulins/FITC for 30 min and 
then were sorted by FACS (Fig.4.5 A left). The mean fluorescence intensity 
was plotted against the numbers of mAb molecules on the beads, and a linear 
regression line ( 2R = 0.9999) was obtained (Fig. 4.5 A, right). Similarly, CHO 
cells were treated with primary anti-c-ErbB2/c-Neu (AB-4) mouse mAb 
(Calbiochem) and secondary FITC-conjugated goat anti-mouse antibody 
provided by the kit. After that cells were sorted under the same calibration 
condition. Fig. 4.5 (B) shows the sorting result of CHO cells; after subtracting 
the background the expression level of endogenous ErbB2 in CHO cells was 
estimated to be ~13,600/cell after interpolating the mean intensity on the 
calibration curve. Fig. 4.5 (C) shows an ACF curve of FCS measurements on 
the surface of CHO cells that were treated with the same primary and 
secondary antibodies. The ACF curves were fit with two dimensional-diffusion 
model and the N value (number of FPs in the focal volume) was obtained. 
After N  was corrected for background (85) and assuming a 400 μm2 surface 
area of CHO cells, the total expression of ErbB2 in CHO cells was calculated 
to be ~ 22,200±5,200/cell.  
 
Several factors may affect the result of the determination of the endogenous 
ErbB2 expression level in CHO cells by FCS.  First, the autofluorescence 
background in CHO cells may vary from cell to cell. For the background 
correlation we used an average background counts (~6,000 kHz ± 2900 kHz) 
that was measured from CHO cells without antibody treatment. The actual  
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Fig. 4.5 Determination of the endogenous expression level of ErbB2 in CHO 
cells by FACS and FCS.  (A) Calibration of the FACS Aria system using the 
kit-provided beads.  (B) FACS sorting of CHO cells pretreated by the FITC-
conjugated anti-ErbB2 antibody. (C) A representative ACF curve of FCS 
measurement on FITC-conjugated antibody bound cell surface ErbB2.   
 
background of the cells in the experiments may vary from the average value 
as CHO cells exhibit a fluctuation of autofluorescence background in different 
cells. Second, there might be some non-specific bindings of the antibodies to 
cell surface. Besides, our calculation was based on the assumption that 
ErbB2 molecules distribute evenly on the cell surface, so that we expanded 
the concentration of ErbB2 in the focal volume to the whole cell surface. This 
assumption may not be accurate since ErbB2 may cluster on the membrane 
(179). FACS experiments avoided this problem as the total fluorescence 
intensity of each cell was measured and sorted accordingly. However, the 
result from FCS is comparable with that from FACS experiments, which 
indicates that FCS may be applied to estimate protein expression levels in live 
cells.  
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In summary, this chapter introduced the characteristics of the ACFs of the 
three FPs and their fusion proteins that were applied to study the biological 
questions in this thesis. Cytoplasmic EGFPs exhibit similar photodynamic 
characteristics as those observed in solution (86). ACFs of the three FPs in 
the cytoplasm can be fitted with the 3D diffusion with two exponential decays 
model and they exhibit different fractions of photodynamic processes. The 
fusion FPs that locate on the plasma membrane of cells can be fitted with the 
2D diffusion of one species with two exponential decays model, and they 
showed slower mobility than that of the cytoplasmic FPs. The fluctuations on 
ACFs of membrane fusion FPs were larger than that of the cytoplasmic FPs, 
possibly due to the thermal dynamic fluctuations of the plasma membrane or 
the heterogeneity of membrane environment. Especially, the molecular 
brightness of EGFR-FPs showed a relative large scale of fluctuations, which 
may indicate that the receptors exist in different tertiary structures on 
membrane. However, cps alone could not answer the question whether the 
receptors exist in monomeric forms or dimeric forms on membrane as cps 
could be affected by several factors. Meanwhile, the translational diffusion 
time of ErbB receptors is determined by the membrane environment and the 
difference in mass between monomeric and dimeric receptors is not 
significant enough to be distinguished from each other. To further investigate 
the tertiary structures of ErbB receptors on native cell membrane, SW-FCCS 
was applied to measure cell samples co-expressing two different FP-fusion 
receptors, as we will introduce in the next chapter.    
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Chapter 5  
SW-FCCS Study on ErbB Receptor Dimerization 
 
To examine whether the ErbB receptors exist in monomeric or dimeric forms 
on cell membrane before ligand stimulation is one key target of this thesis. 
SW-FCCS was performed to study the interactions between two sets of 
homo-ErbB receptors, i.e. EGFR/EGFR and ErbB2/ErbB2, and one set of 
hetero-ErbB receptors, i.e. EGFR/ErbB2. The receptors were fused to either 
EGFP or mRFP, and SW-FCCS measurements were done on cells co-
expressing the two FP-fusion receptors. The results showed that there exist 
dimeric ErbB receptors on the cell membrane before ligand stimulation. 
Quantitation of the dimeric structures of the receptors was carried out, and the 
results were compared with that of the positive and negative controls. 
Comparisons between the dimer percentages of ErbB receptors (~50%) and 
the positive (73%) and negative controls (<20%) indicate that the majority of 
ErbB receptors exist in dimeric forms on the cell membrane before activation. 
To further confirm the dimer percentages measured by SW-FCCS, a third 
untagged EGFR plasmid was added in transfection to compete with the 
interactions between the two FP-fusion EGFRs. With the increase of the 
amount of the third untagged EGFR, the dimer percentage of the two FP-
fusion EGFRs decreases (from 44% to 40%). This reveals SW-FCCS as a 
novel quantitative tool to study protein-protein interactions in vivo.   
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5.1    System calibration 
5.1.1 cps of each FP in the two channels 
In Chapter 2.3.2 we introduced our home-built SW-FCCS setup and dichroic 
mirror/filter sets for the green and red detection channels. The intensity of the 
514 nm excitation laser line was adjusted to ~40 μW for cell measurements. 
Untransfected CHO cells were measured under the same condition, which 
gave the autofluorescence background values of CHO cells in the two 
channels. The following values were the average of 15 measurements (±SD): 
1824 ± 599 kHz (green); 2796 ± 610 kHz (red). We simply put the background 
values as gβ = 1800 and rβ  = 2800 in later calculations. 
 
A series of cell samples expressing single FP or FP-fusion proteins were 
measured under the same experimental setup.  These measurements give 
two sets of values, the cps of each FP or fusion FP in its emission channel, 
such as the cps of EGFR-EGFP in the green channel; and the crosstalk value 
of each FP or fusion FP to the other channel, such as the cps of EGFR-EGFP 
in the red channel. For the EGFP-fusion receptors, EGFR-EGFP showed an 
average value of 1837 ± 448 cps (N=11) and ErbB2-EGFP showed an 
average value of 2176 ± 382 cps (N=12) in the green channel. EGFR-mRFP 
gave an average value of 2047 ± 506 cps (N=18) in the red channel. For 
simplification, we used unique values of Ggη = 2000 and Rrη =2000 for the dimer 
percentage calculations of all co-expression FPs and fusion FPs. Fig. 5.1 
shows the cross-talk of EGFR-EGFP emission into the red channel at different 
cps of EGFR-EGFP. It shows that the higher the cps of EGFR-EGFP, the 
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higher its crosstalk into the red channel. In our calculation a value of Grη = 200 
was used for the crosstalk of EGFP-fusion proteins into the red channel. On 
the other hand, the cross-talk of mRFP-fusion proteins into the green channel 
is almost negligible as mRFP emission maximum is at ~610 nm, which is far 
from the detection range of the green channel (at ~545 nm). So the crosstalk 
from the red channel into the green channel is given by Rgη = 0.  
 
Fig. 5.1 The crosstalk of EGFR-EGFP emission into the red channel. X axis, 
the cps of EGFR-EGFP in the green channel. Y axis, the cps of EGFR-EGFP 
in the red channel. 
 
To summarize, the following values were obtained through calibration under 
the same microscope settings: 
2000Gg =η  
200Gr =η  
0Rg =η  
2000Rr =η  
1800g =β  
2800r =β  
 83
The actual cps of FPs and fusion-FPs may vary in a certain range during SW-
FCCS measurements, as it can be affected by factors such as focusing 
positions or different background values. Later we will show that the 
fluctuation of cps does not strongly affect the calculation of dimer percentages 
since the percentages depend more on the amplitudes of ACFs and CCF. 
 
5.1.2 Positive and negative controls 
In Chapter 3 we introduced the construction of a plasmid encoding mRFP-
EGFR-EGFP. Since the two FPs were linked through the same receptor 
molecule, they should exhibit positive interactions, i.e. positive cross-
correlations. Fig. 5.2 B and C are two sets of ACFs and CCFs  of SW-FCCS 
measurements on mRFP-EGFR-EGFP, the first set measured from cell 
samples with low expression level and the second set measured from cell 
samples with high expression level of mRFP-EGFR-EGFP. Both sets of 
samples showed positive cross-correlation, i.e. the CCF is approaching the 
ACFs. However, at low expression levels the autofluorescence background in 
the two channels contributes highly and effects on the amplitudes of ACFs 
(Eq. (2.13)), especially at the single-molecule level (Fig. 5.2 B right and D 
right). Under such condition as the background in the two channels is different, 
their effects on the amplitudes of the two ACFs are different so that the 
amplitudes of the two ACFs differ from each other. On the other hand, at high 
expression level the total fluorescence intensities in the two channels are 
much higher than the backgrounds, so that the background effect is negligible 
and the amplitudes of the two ACFs are close to each other, i.e. g rN N≈  (Fig. 
5.2 C). This is expected since the two FPs were attached to the same 
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receptor molecule, there should be equal number of green and red particles in 
the two channels. Note in Fig. 5.2 (C) the amplitude of mRFP is still a bit 
higher than that of EGFP, which indicates less fluorescent mRFP fluorophores 
than fluorescent EGFP fluorophores. Fig. 5.2 (D) shows both samples 
expressing high and low level of mRFP-EGFR-EGFP exhibited similar 
fluorescence fluctuations in the two channels as the two FPs were linked by 
the same receptor molecule. On the left graph the single peaks arise from 
single fluorescent particles passing through the focal volume. The blue arrows 
indicate the backgrounds in the two channels are different, which resulted in 
g rN N≠  (Fig. 5.2 B right).      
 
Two sets of co-expression FPs and fusion FPs were used as negative 
controls for SW-FCCS, i.e. co-expression of cytoplasmic EGFP/mRFP and co-
expression of membrane PMT-EGFP/PMT-mRFP. The two cytoplasmic FPs 
locate all through the cytoplasm and do not have specific interactions between 
each other. Similarly, the two membrane-anchored PMT-FPs distribute in the 
inner layer of the membrane bilayer and do not have specific interactions with 
each other. Fig. 5.3 shows the SW-FCCS measurements on the two sets of 
negative controls. The amplitudes of the CCFs are below the ACFs compared 
to that of the positive controls (Fig. 5.2) and approaching amplitude 1, which 
are attributed to the crosstalk of the free species, i.e. the background level. 
Note the amplitudes of the CCFs of the high expression samples (Fig. 5.3 
right column) are more approaching the ACFs compared to that of the low 
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Fig. 5.2 SW-FCCS measurements of cells expressing mRFP-EGFR-EGFP. (A) 
Confocal image of a cell expressing mRFP-EGFR-EGFP. (left) EGFP channel, 
(middle) mRFP channel, (right) overlap of the two channels. Bar, 10 μm. (B) 
Two examples of SW-FCCS measurements from CHO cells expressing low 
levels of mRFP-EGFR-EGFP. Autocorrelation curves of EGFP (green) and 
mRFP (red), and cross-correlation curves (blue) between the two are shown 
with their fits (solid curves). (C) Two examples of SW-FCCS measurements 
from CHO cells expressing high levels of mRFP-EGFR-EGFP. (D) Intensity 
traces during SW-FCCS measurements. (left) Intensity trace of cell sample 
expressing high level of mRFP-EGFR-EGFP. (right) Intensity trace of cell 
sample with single-molecule fluorescence trace. The blue arrows point out 
that the backgrounds in the two channels are different, which causes the 
different amplitudes of EGFP and mRFP in (B, right).   
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Fig. 5.3 ACFs and CCFs measured from CHO cells coexpressing PMT-FPs 
and cytoplasmic FPs. Autocorrelation curves (dashed curves) of EGFP 
(green) and mRFP (red), and cross-correlation curves (blue) between the two 
are shown with their fits (solid curves). (A) Cells coexpressing of PMT-EGFP 
and PMT-mRFP. (left) Low-expression level. Top right, example of image of 
cells co-expressing PMT-EGFP/PMT-mRFP. Bar, 10 μm. (right) High-
expression level. (B) Co-expression of cytoplasmic EGFP and mRFP. Top 
right, example of image of cells co-expressing cytoplasmic free EGFP/ mRFP. 
Bar, 10 μm. (right) High-expression level. 
 
expression samples (Fig. 5.3 left column), which are possibly due to higher 
crosstalk between the two channels at high expression levels of the FPs.  
 
In summary, in this section we first determined the autofluorescence 
background of untransfected CHO cells, the cps of fusion FPs in the detection 
channels and the crosstalk between the two channels. These data were later 
used in the calculation of the dimer percentages of ErbB receptors. SW-FCCS 
measurements on positive control mRFP-EGFR-EGFP showed positive 
cross-correlations on both low- and high-expression samples. At single-
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molecule level although the amplitudes of the ACFs were affected by the 
different backgrounds in the two channels, the CCF still exhibited positive 
cross-correlation, which indicates that SW-FCCS is applicable to detect 
biomolecular interactions at the single-molecule level.  On the other hand, the 
two negative control pairs showed background level CCFs at both low and 
high FP expression levels. Fig. 5.3 (A, right) shows the amplitude of the CCF 
is higher in respect to the ACFs compared to that of Fig. 5.3 (A, left), which is 
possibly due to higher crosstalk at high FP expression level. However, the 
CCF is still at background level compared to that of positive controls. This 
confirms that the system setup is capable of detecting protein-protein 
interactions in live cells.  
 
5.2    SW-FCCS measurements on EGFR/ErbB2 
Cell samples co-expressing EGFP- and mRFP-fusion ErbB receptors were 
prepared using the same electroporation method as for positive and negative 
controls. Compared to the cytoplasmic FPs, internalization of the membrane 
fusion FPs may affect the detection of membrane protein interactions as the 
focal volume includes part of the inner cytoplasm. To inhibit endocytosis of the 
fusion receptors, cells were incubated with reduced serum medium, i.e. 0.1% 
serum for 4-8 hours before SW-FCCS measurements.  Fig. 5.4 shows the 
SW-FCCS results on EGFR/EGFR, ErbB2/ErbB2 homodimerization and 
EGFR/ErbB2 heterodimerization. The amplitudes of cross-correlation curves 
measured from cells coexpressing EGFR-EGFP/mRFP-EGFR (Fig. 5.4 A), 
EGFR-EGFP/EGFR-mRFP (Fig. 5.4 B), EGFR- mRFP/ErbB2-EGFP (Fig. 5.4 
C) or ErbB2-EGFP/ErbB2-mRFP (Fig. 5.4 D), were much higher than those 
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expected for pure cross-talk (black dashed line), which indicates the existence 
of dimeric forms of the receptors on the cell membrane.  
 
 
Fig. 5.4 Auto- and cross-correlation curves measured from CHO cells 
expressing FP-fusion ErbB receptors. Autocorrelation curves of EGFP (green) 
and mRFP (red), and cross-correlation curves (blue) between the two are 
shown with their fits (solid curves). Black dotted lines represent cross-
correlation levels due to cross-talk between the two channels. (A) Cell co-
expressing EGFR-EGFP/mRFP-EGFR. (B) Cell co-expressing EGFR-
EGFP/EGFR-mRFP. (A) and (B) show there exists homodimeric form of 
EGFRs on cell membrane. Comparison between (A) and (B) was to test if 
there was difference in the dimer formation between N- and C-terminus fusion 
receptors. (C) Cell co-expressing EGFR-mRFP/ErbB2-EGFP. This shows the 
heterodimeric interactions between EGFR and ErbB2. (D) Cell co-expressing 
ErbB2-EGFP/ErbB2-mRFP. This shows the homodimeric interactions 
between ErbB2/ErbB2.  
 
5.3   Quantitative analysis to determine the dimer percentages of 
ErbB receptors on the cell surface 
From the ACFs and CCFs one can tell if there is interaction between the two 
FP-fusion molecules, however, further data analysis is needed to quantify the 
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interactions. In Chapter 2.2.1 we introduced the calculation method to 
determine the dimer percentages by using the amplitudes of ACFs and CCF. 
The brightness of each FP, crosstalk and background values were determined 
in section 5.1.1. Thus it is possible to numerically solve Eqs. (2.28-2.30, 2.37, 
2.38) and get Gc  (the concentration of monomeric EGFP-fusion receptors), 
Rc  (the concentration of monomeric mRFP-fusion receptors), GGc (the 
concentration of dimeric EGFP-fusion receptors), RRc (the concentration of 
dimeric mRFP-fusion receptors), and GRc (the concentration of dimers formed 
between EGFP-fusion receptors and mRFP-fusion receptors). Consequently, 
the dimer percentages can be calculated by Eq. (2.40): 
( )
( )
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c c c c c
+ += + + + +                                                                 (2.40) 
Table 5.1 summarizes the dimer percentages of the ErbB receptors 
determined by SW-FCCS measurements. The data from SW-FCCS 
measurements on positive and negative controls were analyzed through the 
same way for comparison.  The positive control gives a dimer percentage at ~ 
73%, which is lower than the ideal 100% expected since the two FPs were 
linked together by EGFR. One important reason may be that not all mRFP 
molecules function as fluorescent molecules, as reported by Hilleshein et al. 
(177). Other factors such as instability of the FPs against photobleaching 
and/or enzymatic degradation may also affect the positive control. With the 
average value of 73% dimerization measured in the positive control, SW-
FCCS suffers from a problem similar to the zero-efficiency peak observed in 
FRET (180) which is caused by the absence of the acceptor on a 
subpopulation of molecules. However, in the case of SW-FCCS this problem 
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is more severe since both the absence of an EGFP as well as the absence of 
an mRFP molecule would lead to a reduced value of dimer formation. When 
comparing the standard deviation of the positive control and the other 
experiments it is evident that the positive control shows a much smaller 
standard deviation. This can be explained by the fact that in this case only FP 
stability determines the fraction of double labeled complexes observed and 
there is no influence of any other biological factors on actual complexation 
between the two fluorophores.  This upper limit of observable dimerization, 
caused by artifacts of the FP stability, leads to an underestimation of the 
actual dimer fraction and these values therefore constitute a lower limit of 
dimerization. We give in Table 5.1 also the dimer fractions normalized to the 
average value of 73% observed in the positive control to show the upper limit 
of dimerization.  
 
The lower limit of dimer formation in the negative controls is probably due to 
the fact that the background values used in our calculations are average 
values over many cells. However, every cell will exhibit a different background 
value which cannot be assessed independently from the expressed FPs. Thus 
there is an uncertainty in the values for the background ( β ) and the 
fluorescence yield (η ) which limits the accuracy of the measurement and 
explains as well the large errors in the dimer fraction. In addition, it should be 
noted that for the PMT-EGFP/-mRFP measurements the correlation times for 
the cross-correlations do not agree with those of the autocorrelations in many 
cases and often the cross-correlations could not be fit at all. This is very 
different from all the other measurements where the correlation times of 
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cross- and autocorrelations do agree. This clearly indicates that there is 
limited cross-correlation seen in the case of the negative controls PMT-
EGFP/PMT-mRFP and free EGFP/mRFP expressed in the cytoplasm.  
 
Table 5.1 Homo- and heterodimer fractions of EGFR and ErbB2 (including third unlabeled 
receptor competition) on the cell surface 
Construct 
Dimer % 
(+ SD) 
Dimer % 
(+ SE) 
Normalized 
Dimer % 
(+SE) 
Sample 
size 
( n ) 
Cytosolic EGFP/ mRFP (negative) 
PMT-EGFP/PMT-mRFP (negative)        
17 ± 9 
19 ± 9 
17 ± 2  
19 ± 2 
23 ± 3 
26 ± 3 
20 
24 
EGFR-EGFP/ EGFR -mRFP 50 + 25 50 + 6  68 ± 8 18 
EGFR-EGFP/ mRFP-EGFR 50 + 25 50 + 5  68 ± 7 21 
EGFR-EGFP/ EGFR-mRFP/ wt EGFR 
(1:1:0.5)* 
44 + 19 44 + 5  60 ± 7 17 
EGFR-EGFP/ EGFR-mRFP/wt EGFR 
(1:1:1)* 
40 + 18 40 + 4  55 ± 5 22 
ErbB2-EGFP/ ErbB2-mRFP 50 + 26 50 + 5  68 ± 7 24 
ErbB2-EGFP/ EGFR-mRFP 62 + 21 62 + 4  85 ± 5 14 
mRFP-EGFR-EGFP (positive) 73 + 15 73 + 4  100 ± 6 14 
*: the ratio (1:1:0.5) was the ratio of amounts (mass) of plasmids used for transfection. So was the ratio 
of 1:1:1.  
 
The dimer percentages observed for the homo- and heterodimers were 
significantly higher (P < 0.001) than that for the negative controls. All the five 
dimer percentages, i.e. the four co-expression pairs of EGFR/ErbB2 (shown in 
Fig. 5.4) together with the positive control,  were similar to one another, and 
might not be significantly different (P > 0.05), indicating that the majority of the 
receptor molecules have dimeric structures on the cell surface. On the other 
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hand, the dimer percentages of co-expression EGFR-EGFP/EGFR-mRFP 
and EGFR-EGFP/mRFP-EGFR, where mRFP is attached to either the C- or 
the N- terminus of EGFR, are the same (50%). This indicates that there is 
either no FRET or no significant influence of FRET on our measurements. 
This is probably due to the fact that mRFP has a long excitation tail on the 
short wavelength side, which allows direct excitation of mRFP by the 514 nm 
line of the laser and makes it a bad FRET acceptor (75). Furthermore, the 
excitation of GFP at 514 nm is reduced so that the direct excitation of mRFP 
largely dominates compared to FRET from GFP to mRFP. This is in 
agreement with the work of Saito et al., who have not found any FRET in a 
EGFP/mRFP pair linked by the D4K linker (102). This experiment 
demonstrates as well that a dimerization due to the interaction between FPs 
can be excluded since for the EGFR-EGFP/mRFP-EGFR the FPs reside on 
different sides of the membrane. 
 
From the different cps detected for cytosolic and membrane-located FPs, it is 
clear that under the experimental conditions used, the cps of the FPs can 
range between about 1000 and 2000 counts. In particular, the cps depends 
on how well the focal volume is focused on the membrane (175). These 
variations could affect the calculation of the dimer fractions. Thus we 
calculated the dimer fractions assuming the lower range of cps of 1100=Ggη , 
100=Grη  , 0Rg =η , and 800=Rrη  but assuming the same background count 
rates as above. However, the dimer fraction determined did not change 
significantly in any of the cases. The fraction of dimers determined depends 
on individual values for the fluorescence yield and background. However, 
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when all the values were changed by the same factor, as would happen in a 
limited range when changing the laser intensity or defocusing from the 
membrane, the dimer fraction determined was almost unchanged. Thus, while 
focusing on the membrane and laser intensity changes can be problems in 
FCS and FCCS (175), the influence of these effects on the dimer fraction is 
small. A simultaneous change of all fluorescence yields and background 
values by a factor of 2 up or down did change the dimer fractions determined 
by less than 2 percentage points, far smaller than the standard deviation. 
Thus the determination of the homo- and heterodimer fraction is stable and 
does not vary strongly with changes in cps. 
 
To further confirm the dimer faction of the receptors obtained from SW-FCCS, 
a third untagged receptor was introduced to the co-expression system of FP-
fusion receptors (i.e. EGFR-EGFP/EGFR-mRFP) by adding a third wild-type 
EGFR (wt EGFR) plasmid (pNUT/EGFR) in transfection. The third wt EGFR 
would compete with the dimer formation between EGFR-EGFP and EGFR-
mRFP, thus a decrease of dimer fraction should be observed. This is shown 
in Table 5.1 with two sets of triple-transfection data. The dimer faction of 
EGFR-EGFP/EGFR-mRFP decreases with the increase of the amount of the 
third plasmid. With the increase of the ratio of EGFR-EGFP/EGFR-mRFP/wt 
EGFR from 1:1:0.5 to 1:1:1, the dimer faction drops from 44% to 40%, and 
both are lower than that of the co-expression of EGFR-EGFP/EGFR-mRFP 
(50%). Note that the ratio was the mass ratio among the three plasmids and 
the molar ratio may be different (which depends on the vector size). Besides,  
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Fig. 5.5 Dimerization percentages vs. receptor expression level. (A) 
Coexpression of EGFR-EGFP/EGFR-mRFP, and coexpression of EGFR-
EGFP/mRFP-EGFR. (B) Coexpression of ErbB2-EGFP/ErbB2-mRFP. (C) 
Coexpression of EGFR-EGFP/ErbB2-mRFP. (D) Positive control mRFP-
EGFR-EGFP, and negative control coexpression of PMT-EGFP/PMT-mRFP. 
The shaded area indicates the physiological expression level of EGFR/ErbB2 
(<105/cell).  
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each individual cell may take in different amounts of the plasmids. As the third 
untagged receptor is not detectable in SW-FCCS and the concentration of wt 
EGFR may differ from cell to cell, the competition effect may differ from that 
estimated by the plasmid ratio. However, the averaged values of the dimer 
fraction from different sets of cell samples still indicates the competition effect,  
which reveals SW-FCCS as a quantitative technique to investigate molecular 
interactions in live cells. Furthermore, these dimer percentages were not 
affected by the receptor expression levels ranging from 2.0 x 104 to 2.6 x 105 
molecules per cell (Fig. 5.5). This indicates that the receptor homo- and 
heterodimerization are not dependent on receptor expression levels, as 
previously observed for EGFR homodimerization (25).  
 
5.4 SW-FCCS investigation on EGFR dimerization using 
EYFP/mRFP pair 
In the beginning we considered to use 488 nm laser line to excite EGFP and 
mRFP, and found that at 488 nm the emission of EGFP was too strong with a 
high crosstalk into the red channel. On the other hand, the excitation of mRFP 
at 488 nm was not sufficient enough to overcome the crosstalk from EGFP. At 
514 nm excitation mRFP can be excited and gives good fluorescence signal. 
Since 514 nm is the excitation maximum of EYFP, we also tested if SW-FCCS 
can be done on EYFP- and mRFP-fusion pair. First we tested the crosstalk of 
EYFP into the red channel (Fig. 5.6 A). The crosstalk is much higher than that 
of EGFP, possibly due to two reasons. First, the emission of EYFP is further 
shifted to the red than that of EGFP. Second, the brightness of EYFP is higher 
than that of EGFP since at 514nm EYFP can be excited more efficiently, so 
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that it gives higher crosstalk to the red channel as the crosstalk is proportional 
to the brightness of the green particles. 
Similar to the EGFP/mRFP pair, EGFR-EYFP and EGFR-mRFP were 
coexpressed in CHO cells and measured under the same system setup. Fig. 
5.6 (C) shows that positive CCFs were obtained from SW-FCCS 
measurements. However, due to the high crosstalk of EYFP into the red 
channel, the expression level of EGFR-mRFP must be higher than that of 
EGFR-EYFP in order to overcome the crosstalk. From the amplitudes of the 
two ACFs (Fig. 5.6 C), one would estimate that the concentration of EGFR-
mRFP should be at least three times higher than that of EGFR-EYFP. In Fig. 
5.6 D (right) the intensity trace shows that comparable intensities in the two 
channels can be obtained under the condition that the expression of EGFR-
mRFP is three times more than that of EGFR-EYFP. For the negative control, 
erythropoietin receptor (EpoR) was fused to EYFP and was co-expressed with 
EGFR-mRFP. There is no interaction between EpoR and EGFR (52), so that 
a background level CCF was obtained (Fig. 5.6 B). It was difficult to get 
comparable signals of fusion EGFR and EpoR for SW-FCCS measurements. 
Later through confocal imaging we found that a large portion of EpoR located 
on the endoplasmic reticulum (ER) membrane of the cells. This may be the 
reason that we could hardly detect two comparable signals on the cell 
membrane.    
 
In summary, we show here that it is possible to perform SW-FCCS at 514 nm 
laser excitation using EYFP/mRFP pair. EYFP gives a higher crosstalk to the 
red channel than EGFP, and mRFP fusion proteins need to be expressed  
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Fig. 5.6 SW-FCCS measurements using EYFP/mRFP pair. (A) cps of EYFP 
in the green channel vs. cps of EYFP crosstalk into the red channel. (B) ACFs 
and CCF of co-expression of EpoR-EYFP and EGFR-mRFP (negative 
control). The CCF is flat and approaching 1. (C) ACFs and CCFs of cells co-
expressing EGFR-EYFP and EGFR-mRFP. Positive CCFs were obtained, 
which indicate the interactions between EGFRs. (D) Intensity traces during 
SW-FCCS measurements. (left), co-expression of EpoR-EYFP and EGFR-
mRFP. The intensity peaks (pointed by purple arrows) in the two channels do 
not come out at the same time, which indicate there is no interaction between 
the two fusion receptors. (right), co-expression of EGFR-EYFP and EGFR-
mRFP. Some intensity peaks (pointed by purple arrows) came out 
simultaneously, which indicate the interactions between fusion EGFRs.   
 
more than EGFP fusion proteins in order to overcome the crosstalk, as 
discussed Bacia and Schwille (87). In contrast, EGFP/mRFP pair gives 
comparable signals in the two channels and the crosstalk between the two 
channels is much less. Therefore, we would recommend using the 
EGFP/mRFP for SW-FCCS excitation at 514 nm. 
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5.5    Summary 
In this chapter SW-FCCS was performed to investigate the interactions 
between ErbB family receptors. Results showed that there exist dimeric forms 
of EGFR/EGFR, ErbB2/ErbB2 and EGFR/ErbB2 on the cell surface before 
ligand stimulation. Quantitative analysis on SW-FCCS results indicates that 
the majority of the receptors form dimeric structures on native cell membranes. 
This reveals a new possible activation mechanism of ErbB receptors which is 
not consistent with the conventional “dimerization model”. In the next chapter 
we will introduce experiments that were done on the receptors after ligand 
activation. Further discussion and summary on the receptor activation 
mechanism will be given in the next chapter.  
 
This chapter shows that SW-FCCS can be performed to detect molecular 
interactions in live cells. Both EGFP/mRFP and EYFP/mRFP pairs can be 
applied for SW-FCCS excitation at 514nm. However, EYFP gives a higher 
crosstalk to the red channel and at least three times higher concentration of 
mRFP is needed to overcome the crosstalk. On the other hand, EGFP and 
mRFP give comparable signals in the two channels with minimum crosstalk 
between each other. Therefore, it is recommendable to adopt the combination 
of EGFP/mRFP for SW-FCCS at 514 nm excitation. Quantitative analysis of 
positive, negative controls and the three-transfection competition experiments 
shows that SW-FCCS is applicable to quantify biomolecular interactions in 
vivo.  
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Chapter 6  
Activation of ErbB Receptors Using EGF Stimulation  
 
Three experiments were carried out on FP-fusion EGFRs after EGF 
stimulation, phosphorylation assay, imaging of receptor internalization and 
FCS/SW-FCCS observations. The first two experiments were functional tests 
of the fusion receptors, i.e. to check whether the FP-fusion affects the 
physiological activities of the receptors or not. FP-fusion EGFRs were 
phosphorylated after ligand stimulation, and endocytosis of the fusion 
receptors were observed by confocal imaging. This proves that FP-fusion 
does not affect the physiological functions of the receptors. Both FCS/SW-
FCCS observed slower mobility of the receptors after ligand binding, as well 
as aggregation or clustering of the receptors on the cell surface. The results 
indicate that FCS/SW-FCCS may be applied to monitor membrane receptor 
activation in vivo.  
 
6.1    Phosphorylation assay  
In Chapter 1.2.1 we introduced the signaling procedure of ErbB receptors. 
Ligands such as EGF bind to the extracellular domain of the receptor and 
induce activation of the intracellular kinase domain of the receptor, so that the 
residues on the C-terminus domain of the receptor are phosphorylated. 
Phosphorylation of the receptor is essential for the intracellular signal 
transduction. In our study the receptors were fused with FPs either at its N-
terminus or C-terminus, which might affect the physiological functions of the 
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receptor. Thus we set out to test whether the fusion receptors can still be 
activated and phosphorylated. In Chapter 3.2 we introduced the experimental 
procedure of the phosphorylation assay. EGFR constructs were introduced 
singly into COS-7 cells, as COS-7 cells give higher protein expression levels 
compared to CHO cells. Fig. 6.1 shows the results of the phosphorylation 
assay on EGFR constructs. wt EGFR was tested under the same 
experimental conditions for comparison (lane 1 and 2 from left). Both the C-
terminal fusion construct EGFR-EGFP, and the N-terminal fusion construct 
mRFP-EGFR, were phosphorylated upon EGF binding (lane 4 and 6). Note in 
lane 4 a lower band with similar size as that of wt EGFR was detected. This is 
a result from the fact that COS-7 cells express detectable endogenous EGFR. 
A similar band can not be detected in the lane of mRFP-EGFR (lane 6), as the 
relative expression level of mRFP-EGFR is higher than that of EGFR-EGFP, 
while the expression level of EGFR-EGFP is comparable with that of wt EGFR 
in COS-7 cells. Lane 8 shows the endogenous expression of wt EGFR in 
COS-7 cells is detectable. For another reference, A431 cells which over 
express wt EGFR was also tested (lane 9). In summary, the phosphorylation 
assay shows that FP-fusion does not affect the physiological function of the 
receptors. This is consistent with the report by Clayton et al. (181), who found 
that EGFP fusion does not affect the phosphorylation of the fused EGFR.   
 
Some issues of the experimental conditions in the phosphorylation assay 
should be addressed here. First, a concentration of 100 ng/ml EGF was used 
for the stimulation of the receptors before cell lysis. Similar concentrations are 
commonly used, i.e. 100 ng/ml EGF  or 10 nM (~60 ng/ml), to stimulate the  
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 Fig. 6.1 Phosphorylation assay of FP-fused EGFR constructs. The chimeric 
constructs were introduced into COS-7 cells, and the cell lysates were 
prepared before (-) and after (+) stimulation with EGF.  The lysates were 
blotted on filter membranes, and stained with anti-EGFR antibody (α-EGFR) 
or anti-phosphotyrosine antibody (α-pTyr). Note that COS-7 cells express the 
wild-type EGFR detectable by staining with the antibodies, particularly in the 
lanes of EGFR-EGFP and untransfected COS-7. As a reference, a cell lysate 
of A431, which over expresses the wild-type EGFR, was also included in the 
lane furthest to the right. Arrow heads indicate the positions of a molecular 
marker, 204-kDa myosin heavy chain. 
 
receptors (169, 170, 182-187). The threshold of EGF concentration to initiate 
detectable phosphorylation of wt EGFR is 1.0 ng/ml (188) and for EGFP-
fusion EGFR the concentration was used up to 500 ng/ml (181). Second, the 
cells were incubated with 100 ng/ml EGF on ice but not at 37°C. This was to 
prevent the receptor internalization (170), otherwise the receptor will be 
internalized and degraded and the receptor molecule will not be observed as 
a discrete band. On the other hand, incubation with EGF at 37°C allows 
internalization of the receptors, so that 37°C incubation is normally applied for 
the detection of the phosphorylation and activation of the intracellular 
downstream signaling proteins and proteins that are involved in the receptor 
endocytosis (169, 189). Third, incubation on ice slows down the reaction 
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dynamics, so that a longer stimulation time (30 min) was chosen compared to 
the incubation time at 37°C. To incubate cells with EGF on ice or at 4°C can 
take up to 60 min or hours (190). 
 
6.2 Imaging of FP-fusion EGFR internalization after EGF 
stimulation 
Imaging of the internalization of the fusion receptors was carried out on a 
laser scanning confocal microscope LSM510 (Carl Zeiss). Cells were grown 
on circular cover glasses (Lakeside), and the cover glass was set in a POC 
mini chamber (Carl Zeiss) and covered by D-MEM /F-12K medium lacking 
phenol red (Gibco). The chamber was set in the heating stage which was 
adjusted to 37°C by the Tempcontrol 37-2 digital (Carl Zeiss), for incubation of 
the cells at 37°C allowing internalization of the receptors. Fig. 6.2 shows the 
images of the internalization of the FP-fusion receptors after EGF stimulation. 
Before ligand stimulation, the fluorescence was shown clearly on the 
periphery of the cells (Fig. 6.2 left), which indicates that the fusion receptors 
were located on the cell membrane before activation. EGF was added 
dropwise into the PBS solution to a final concentration of 100 ng/ml. The C-
terminal fusion EGFRs, EGFR-EGFP and EGFR-mRFP (the first two rows in 
Fig. 6.2), showed relatively faster internalization than that of the N-terminal 
fusion receptor mRFP-EGFR (the last row in Fig. 6.2). The C-terminal fusion 
EGFRs on the cell surface were efficiently internalized within 30 min or less, 
while the N-terminal fusion EGFRs took up to 50 min for complete 
internalization. This suggests that FP fusion with EGFR at its N-terminus may 
affect the binding efficiency of the receptor for EGF. Nonetheless, both the N- 
 103
and C-terminal fusion receptors were internalized after ligand stimulation. This 
indicates that FP-fusion does not affect the physiological function of the 
receptor, which is consistent with the phosphorylation results.   
 
 
Fig. 6.2 FP-fusion EGFR internalization after EGF stimulation. (left) Images 
before adding EGF; (middle) images  show a certain scale of internalization 
after certain time of EGF stimulation; (right) images show large scale of 
internalization after longer time of EGF stimulation. Bar, 10 μm. 
 
6.3   FCS/SW-FCCS observations on the activation of FP-fusion 
EGFRs by using EGF stimulation 
           6.3.1 FCS observations on EGFR-EGFP activation  
The experimental setup was the same as the setup for the characterization of 
photodynamic properties of EGFP in Chapter 4, i.e. excitation laser line was  
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Fig. 6.3 FCS observations on two cells expressing EGFR-EGFP before and 
after EGF activation. Before adding EGF the fluorescence fluctuations are 
relatively regular and the diffτ  obtained from fitting the two ACFs are similar (A 
and B, left). After adding EGF, slower diffusion was observed in the first cell 
(A, right), and irregular fluorescence fluctuation peak with high intensity was 
observed in the second cell (B, right).  
 
488 nm and 510AF23 (Omega) was placed in front of the detector as an 
emitter. FCS measurements were performed by focusing on the same spot on 
the top membrane of a single cell before and after adding EGF. Different 
phenomena were observed on different cells after EGF activation. Fig. 6.3 
shows two typical phenomena that were observed on two cells after adding 
EGF. The ACFs of FCS measurements on the two cells before adding EGF 
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are similar (Fig. 6.3 A and B, left). EGF was added dropwise into the PBS 
buffer in the chamber to a final concentration of 100 ng/ml. The first FCS 
measurement on the first cell after adding EGF exhibited a much longer 
diffusion time compared to the diffτ  before adding EGF (108 ms vs. 30 ms). 
This indicates EGF binding slows down the mobility of the receptor. The long 
diffτ   of EGFR-EGFP after adding EGF is consistent with the diffτ  measured 
by adding Rh-EGF to the cell surface wt EGFR (31) (108 ms vs. 100 ms), 
which confirms that the long diffτ  observed here represents the mobility of the 
EGF-bound receptor complex.  
 
In contrast, a different phenomenon was observed on the second cell. The 
first FCS measurement on the second cell after adding EGF (Fig. 6.3 B, right) 
showed a smaller diffτ  (8 ms vs. 41 ms), together with fast decay of the 
fluorescence intensity (Fig. 6.3 B, right, the intensity trace is shown below the 
ACF graph). Moreover, an irregular fluorescence fluctuation (high intensity 
peak) was observed (Fig. 6.3 B, right, pointed out by a solid arrow the 
intensity trace). The abnormal high intensity peak possibly indicates the 
activated receptors form higher-order oligomers such as tetramers (181), or 
the activated receptors may aggregate or cluster into specific membrane 
microdomains (191). The smaller  diffτ  obtained from fitting ACF in Fig. 6.3 (B, 
right) indicates the existence of receptors with similar mobility to that before 
adding EGF ( diffτ  is smaller possibly due to the fast photobleaching as 
observed in the intensity trace). Hence, FCS measurements on the second 
cell (Fig. 6.3 B) indicate that there are different forms of the receptors on the 
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membrane after adding EGF, including higher-order oligomers or aggregates 
(revealed by irregular high fluorescence intensity peak), and some receptors 
with similar forms like the forms before adding EGF (revealed by similar 
diffusions like the diffusion before adding EGF). The different forms of the 
receptors may correspond to the different classes of receptors with either high 
or low affinities to ligand. Two classes of EGFR have been reported according 
to their respective binding affinity to EGF, i.e. high affinity and low affinity, and 
the signal transduction is mediated by the subclass of high affinity receptors 
(190). The receptors that remain at similar mobility after adding EGF may be 
the subclass of low affinity receptors, and the receptors that form 
oligomer/aggregates may be the high affinity receptors which are activated by 
EGF and in turn process signal transduction. Further experiments, such as 
multi-color SW-FCCS, may be carried out by labeling EGF, the receptor and 
adaptor molecules with different fluorophores, to test the hypothesis.    
 
The phenomena in Fig. 6.3 (A) and (B) were both observed by the first FCS 
measurement after adding EGF. This may be due to that EGF was added 
directly near the position of the focused cell. It takes a few seconds to start 
running FCS again after adding EGF, and activation of the receptor happen in 
seconds time scale. So at the time FCS was turned on again it observed the 
behaviors of activated receptors. For a relatively longer time and stable 
observation, EGF was added at positions away from the focused cells. For 
instance, if the focused cell was in the center of the cover glass, then EGF 
was added in at the periphery region of the cover glass and without 
thoroughly mixing. Therefore it would take some time for EGF molecules to 
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diffuse to the membrane of the focused cells before activating the receptors. 
Fig. 6.4 shows one example of such experiments.    
 
 
Fig. 6.4 Continuous FCS observations on a cell expressing EGFR-EGFP 
before and after EGF activation. Dashed line, raw data points; solid line, fitting 
curve. (A) ACF curve of the FCS measurement before adding EGF. (B) ACF 
curve of the first FCS measurement after adding EGF. (C) ACF curve of the 
fourth FCS measurement after adding EGF. (D) ACF curve of the seventh 
FCS measurement after adding EGF.   
 
For comparison, FCS measurements were continuously run for five times on 
the same cell before adding EGF. All the five measurements showed similar 
diffτ  at tens of milliseconds time-range as usually observed. Fig. 6.4 (A) 
shows the ACF curve of the last measurement (in the total five 
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measurements), i.e. the one right before adding EGF. After adding EGF, the 
first three FCS measurements showed similar ACFs to that before adding 
EGF. Fig. 6.4 (B) shows the ACF of the first measurement after adding EGF, 
which is similar to (A). Slower diffusion of the receptors was observed from 
the fourth FCS measurement after adding EGF (Fig. 6.4 C), which indicates 
that the receptors were bound by EGF molecules at that time. Following FCS 
measurements also showed irregular high intensity fluorescence peaks 
(pointed out by small solid arrows in the intensity trace in Fig. 6.4 D). The ACF 
in Fig. 6.4 D is not fitted well (the solid line does not overlap well with the 
dashed line in the diffusion time scale) with one species model, possibly 
because there exist different forms of the receptors (higher-order oligomers or 
aggregates together with receptors with normal diffusion) during the 
observation period. In all, the experiment in Fig. 6.4 confirms that both 
phenomena in Fig. 6.3 (A) and (B), i.e., slow diffusion and 
oligomerization/aggregation (indicated by irregular high fluorescence peak),  
can be observed after adding EGF to activate the receptors. Similar 
phenomena were observed in the experiments carried out on over 20 cell 
samples.  
    
6.3.2 SW-FCCS observations on FP-fusion EGFRs on cell surface 
after EGF stimulation 
In Chapter 5 we introduced SW-FCCS investigations on the dimerization of 
the ErbB receptors before ligand stimulation. The results show that a large 
portion of the receptors exists in dimeric structures on native cell membrane 
before ligand stimulation. This is in conflict with the “dimerization model”, 
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which assumes that the receptors dimerize only after ligand stimulation. To 
observe if the ligand binding affect the dimerization of the receptors, EGF was 
added to the cell sample which co-express EGFR-EGFP and EGFR-mRFP 
(Fig. 6.5). To avoid the fast internalization of the receptors, the cell samples 
were incubated with endocytosis inhibitors for half an hour before observation. 
Under this condition the receptors could be kept on the membrane after ligand 
binding for relatively long period so that changes in the dimerization of the 
receptors could be observed. In the first minutes changes are small and the 
ACF and CCF curves are similar to the state before EGF stimulation (Fig. 6.5, 
A and B). This indicates that the ligand binding does not greatly affect 
receptor dimerization. After a longer time of about 10 min after adding EGF, 
irregular high intensity fluorescence peaks were detected (Fig. 6.5, C and D), 
consistent with FCS observations of receptor oligomerization or clustering on 
the membrane (section 6.3.1), as pointed out by the arrows in Fig. 6.5 (C) and 
(D). In Fig. 6.5 (C) the two irregular high intensity peaks (pointed out by 
arrows) showed distinctive intensity values, which indicates the oligomers or 
aggregates are in different sizes, i.e. each oligomer/aggregate contains 
different numbers of the receptors. This is consistent with the reports that the 
activated receptors may form tetramers or even higher-order oligomers (53, 
181).  Note the CCFs in Fig. 6.5 (C) and (D) are close to the ACFs. This is 
because when large aggregates appear during FCS measurments, the ACF is 
determined mainly by the aggregates. As the EGFP- and mRFP-fusion 
receptors form aggregates together, both channels detected aggregates and 
the CCFs are determined by the aggregates, so that the CCFs are close to 
the ACFs. The time to observe aggregates, clusters or oligomers of the 
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receptors was longer than the time to observe similar phenomena by FCS 
measurements (section 6.3.1), which may be due to that ATP depletion slows 
down the activation process of the receptors. In summary, the SW-FCCS 
observation on the co-expressed receptors after EGF activation agrees with 
the preformed dimer results (Chapter 5) and aggregation or oligomerization of 
the receptors after activation (section 6.3.1).   
 
 
Fig. 6.5 Auto- and cross-correlation curves measured from one CHO cell 
expressing EGFR-EGFP/EGFR-mRFP before and after ligand stimulation. (A) 
ACF and CCF curves before adding EGF. (B), (C) and (D), 4 min, 11 min and 
13 min after EGF stimulation, respectively.  
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6.4 Discussion 
The FCS/SW-FCCS studies on the interactions between ErbB receptors 
(Chapter 5 and this chapter) shed light on the activation process of the 
receptors. First, the ErbB receptors exist in different forms on native cell 
membrane before ligand stimulation. A large portion of the receptors exist in 
dimeric form before ligand binding. In this thesis we investigated the 
homodimeric structures of EGFR and ErbB2, as well as heterodimeric 
structures of EGFR/ErbB2. The membrane receptors exhibit similar mobility 
before activation. The receptor homo- and heterodimers on the cell surface 
may be able to take two major structures, one with an intra-molecular tether, 
which is similar to ligand-unbound EGFR, and the other with an untethered 
structure like ErbB2 (192). These two structures may correspond to the 
receptors on the cell surface, which have low and high affinities for EGF, 
respectively (192). Second, a certain fraction of the receptors showed slower 
diffusion soon after adding EGF, indicating the high affinity receptors are 
activated and signal transduction occurs (190). Third, irregular fluorescence 
fluctuations with much higher fluorescence intensity than that of normal 
diffusion of the fusion receptors were also observed, indicating either the 
dimeric receptors form oligomers such as tetramers (181) or even higher-
order oligomers, or the activated receptors form aggregates or clusters. 
Besides, the measurements which showed that the receptors exhibit similar 
mobility to that before ligand stimulation indicate the diffusion of the low 
affinity receptors on the membrane. Activation of the low-affinity receptors 
may occur through cross-phosphorylation by high-affinity receptors, and 
cross-phosphorylation take place between dimers of both receptor types (190). 
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Under such condition the high intensity fluorescence peaks could possibly 
represent dimer-dimer interactions between the two subclasses of the 
receptors, i.e. the tetrameric complex (181).    
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Chapter 7   
SW-FCCS Studies on Cdc42-related Signaling Complexes 
 
In the previous chapters SW-FCCS was applied to study the interactions 
between ErbB receptors on the cell surface. Activation of the receptors 
initiates diverse intracellular downstream signaling cascades (43). For 
instance, the guanine nucleotide exchange factor Vav2 is tyrosine 
phosphorylated in response to EGF, and it in turn activates Rho family 
GTPases including Rac1, Cdc42 and RhoA (19). In this chapter, SW-FCCS 
was further applied to investigate interactions between activated Cdc42 and 
its effectors. The effectors include two proteins containing a CRIB/partial 
CRIB motif, i.e. IRSp53 and NWASP, as well as one non-CRIB-containing 
effector Toca-1 (65). SW-FCCS data analysis shows that the two types of 
effectors exhibited different dissociation constants, indicating that SW-FCCS 
may be applied to investigate the binding strength of interacting partners in 
live cells. SW-FCCS was further applied to study the dimerization of IRSp53, 
which reveals that IRSp53 forms a certain percentage of dimers inside the cell.    
 
7.1   SW-FCCS investigation on the interactions between Cdc42 
and its effectors 
7.1.1 Positive and negative controls 
It has been shown that the combination of EGFP/mRFP is suitable for SW-
FCCS measurements at excitation wavelength of 514 nm, as on such a 
system setup the fluorescence signals of the two FPs are comparable in the 
 114
two detection channels and crosstalk between the two channels is minimized 
(Chapter 5). Hence in this chapter Cdc42 and its effectors were fused to either 
EGFP or mRFP by means of a linker sequence with several amino acid length 
(Chapter 3.1.5). As these proteins locate in the cytoplasm of cells, a plasmid 
encoding EGFP-mRFP was made as a cytoplasmic positive control. The two 
FPs are linked through a four amino acid linker, so that this construct should 
exhibit a positive CCF between the two channels. In Chapter 5 the co-
expression of cytoplasmic free EGFP and mRFP exhibited background level 
CCFs, as there is no specific interaction between the two FPs. This pair could 
also be used as a negative control here. For another negative control pair, 
EGFP-Cdc42V12 and mRFP were co-expressed in CHO cells. This pair should 
also exhibit uncorrelated background level CCF as there is no specific 
interaction between EGFP-Cdc42V12 and free mRFP. Fig. 7.1 shows the ACFs 
and CCFs of the positive control EGFP-mRFP, and the negative control, co-
expression of EGFP-Cdc42V12 and mRFP. A positive CCF is obtained from 
SW-FCCS measurement on the cell expressing EGFP-mRFP (Fig. 7.1 A, left). 
On the other hand, there is no specific interaction between EGFP-Cdc42V12 
and mRFP, so that an uncorrelated background level CCF is obtained (Fig. 
7.1 A, right).  
 
Ideally, the positive control EGFP-mRFP should exhibit 100% binding 
between the EGFP and mRFP since the two FPs are fused in tandem into the 
same vector with 1:1 ratio. This means that the amplitudes of the two ACFs 
should be the same ( g rN N≈ ), and the amplitude of the CCF should be equal 
to that of the ACFs. However, Fig. 7.1 (A) shows the amplitude of EGFP is 
 115
smaller than that of mRFP, which means the system detected more EGFP 
molecules than mRFP molecules (Eq. (2.8)). This is possibly due to the fast 
photobleaching rate of mRFP in the fusion proteins (177). Fig. 7.1 (B) shows 
that the fluorescence intensity in the red channel decreases much faster than 
that in the green channel, indicating mRFP molecules were photobleached 
much faster than EGFP molecules. At the end only around half of the EGFP-
mRFPs remained both fluorescent while in the other half only EGFP was still 
emitting fluorescence. Therefore in the cytoplasm SW-FCCS observes a  
 
 
Fig. 7.1 Auto- and cross-correlation curves measured from CHO cells 
expressing (A) EGFP-mRFP (positive control) and (B) EGFP-Cdc42V12/mRFP 
(negative control). Autocorrelation curves of EGFP (green) and mRFP (red), 
and cross-correlation curves (blue) between the two are shown with their fits 
(solid curves). (A) (left) ACF and CCF curves of positive control EGFP-mRFP. 
(right) ACF and CCF curves of the negative control, co-expression of EGFP-
Cdc42V12 and cytoplasmic free mRFP. (B) Fast photobleaching of mRFP in 
the EGFR-mRFP construct as seen by the intensity trace. (left) The first 30 
sec measurement. At the beginning the green and red signals are on the 
same level (at ~140 kHz), and 30 sec the red signal dropped to at ~ 80 kHz. 
(right) The second 30 sec measurement. The intensity in the red channel 
drops to ~70 kHz and the signal in the green channels is at ~135 kHz, which 
shows that the red signal has dropped around 50% compared to the green 
signal.  
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mixture of EGFP-mRFP (both fluorescent) and EGFP-mRFP* (mRFP*: 
nonfluorescent mRFP), and maybe a small fraction of EGFP*-mRFP (EGFP*: 
nonfluorescent EGFP) as EGFP is more photostable. Consequently, SW-
FCCS detected more fluorescent EGFP molecules than fluorescent mRFP 
molecules ( g rN N> ), so that (0) (0)g rG G< . SW-FCCS detects the mixture of 
EGFP-mRFP (both FP are fluorescent) and EGFP-mRFP*/EGFP*-mRFP (*: 
nonfluorescent FP), so that the amplitude of CCF is smaller than that of ACFs 
(apparently not 100% binding between EGFP and mRFP). This is similar to 
previous observation of the membrane positive control mRFP-EGFR-EGFP 
(Chapter 5.1.1), where only an average of 73% dimer percentage was 
observed which ideally should be 100%.   
 
7.1.2 Interactions between Cdc42 and its effectors 
In Chapter 3.1.5 we introduced two forms of Cdc42, i.e. the constitutively 
active mutant Cdc42V12 and the dominant negative mutant Cdc42N17, were 
fused to EGFP, and the three effector proteins were fused to mRFP 
accordingly. SW-FCCS measurements were carried out on cells co-
expressing EGFP-Cdc42V12/mRFP-NWASP (Fig. 7.2 A), EGFP-
Cdc42V12/mRFP-IRSp53 (Fig. 7.2 B), and EGFP-Cdc42V12/mRFP-Toca1 (Fig. 
7.2 C). The three co-expression pairs exhibit positive CCFs, which indicates 
both the CRIB-containing effectors (Fig. 7.2 A and B) and the non-CRIB 
containing effectors (Fig. 7.2 C) interact with Cdc42V12. To further confirm the 
interactions, SW-FCCS was also carried out on the co-expression of the 
dominant negative mutant EGFP-Cdc42N17/ mRFP-IRSp53 (Fig. 7.2 D) and 
EGFP-Cdc42N17/mRFP-Toca1 (Fig. 7.2 E). Both co-expression pairs in Fig. 
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7.2 (D) and (E) exhibit CCFs with amplitudes much lower than the ACFs 
(approaching 1), which confirmed the interactions in Fig. 7.2 (A)-(C).  
 
 
Fig. 7.2 Auto- and cross-correlation curves measured from CHO cells co-
expressing FP-fusion Cdc42 mutants and the effectors. Autocorrelation 
curves of EGFP (green) and mRFP (red), and cross-correlation curves (blue) 
between the two are shown with their fits (solid curves). (A) Cells co-
expressing EGFP-Cdc42V12 and mRFP-NWASP. (B) Cells co-expressing 
EGFP-Cdc42V12 and mRFP-IRSp53. (C) Cells co-expressing EGFP-Cdc42V12 
and mRFP-Toca1. (D) Cells co-expressing EGFP-Cdc42N17 and mRFP-
IRSp53. (E) Cells co-expressing EGFP-Cdc42N17 and mRFP-Toca1. 
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7.1.3 Plot of the equilibrium dissociation constant DK  
The ACFs and CCF curves qualitatively tell whether there is interaction or no 
interaction between molecules, and further data analysis is needed for 
quantification of the interactions. In Chapter 5 we quantified the dimer 
percentages of ErbB receptors on cell surface. Similar data analysis can be 
performed to quantify the percentages of the Cdc42/effector interacting 
complexes using Eq. (2.24) and Eq. (2.25) (Chapter 2.2.1). As we discussed 
in Chapter 2.2.1, the complex percentage Gf  or Rf  depends greatly on the 
relative expression levels of the two fusion proteins. In this chapter EGFP and 
mRFP were fused to different types of proteins and often cells do not express 
the two fusion proteins at the same level. The concentrations of two FP-fusion 
proteins also vary from cell to cell. To overcome this shortage, an alternative 
way is to create a plot for the equilibrium dissociation constant DK , which is 
not affected by the relative concentrations between EGFP and mRFP. The 
theory for DK  plot from analyzing SW-FCCS data has been introduced in 
Chapter 2.2.1. Basically, from the amplitudes of ACFs and CCF the 
concentrations of bound- and un-bound molecules are determined. In our 
system, Gc  represents the concentration of the un-bound EGFP-fusion 
proteins, Rc  represents the concentration of the un-bound mRFP-fusion 
proteins, and GRc  represents the concentration of the interacting complexes. 
The dissociation constant DK  at equilibrium is then determined by plotting 
Gc × Rc vs. GRc  (the slope of the plot gives the value of DK ) (Eq. 2.26).  
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Fig. 7.3 Determination of DK . Plots of 
Gc × Rc vs. GRc  from SW-FCCS 
measurements on cells expressing (A) EGFP-Cdc42V12/mRFP-IRSp53, (B) 
EGFP-Cdc42V12/mRFP-NWASP, (C) EGFP-Cdc42V12/mRFP-Toca1, (D) 
EGFP-mRFP (positive control), (E) EGFP-Cdc42N17/ mRFP-IRSp53, (F) 
EGFP-Cdc42N17/ mRFP-Toca1, and (G) EGFP-Cdc42V12/mRFP (negative 
control). The slope of the plot gives the DK  value. 
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Fig. 7.3 shows the DK  plot for each co-expression pair of Cdc42 and effectors 
(A-C, E, F), together with the positive (D) and negative controls (G). The two 
co-expression pairs of Cdc42V12 and the CRIB-containing effectors both 
exhibit a linear regression line (Fig. 7.3 A and B), so that a DK  value for each 
pair is obtained (summarized in Table 7.1). Similarly, the co-expression pair of 
Cdc42V12 and the non-CRIB-containing effectors (Fig. 7.3 C) exhibit linear 
regressions and DK  value is obtained from the slope of the regression line 
(value is given in Table 7.1). For comparison, Gc × Rc vs. GRc  was also plotted 
for the co-expression pairs of the dominant negative Cdc42N17 with mRFP-
IRSp53 (Fig. 7.3 E) or mRFP-Toca1 (Fig. 7.3 F). No linear regression is 
obtained for the co-expression pair of Cdc42N17/ mRFP-Toca1, which 
indicates there is no interaction between Cdc42N17 and mRFP-Toca1. A poor 
regression line (the coefficient of determination 2R <0.1) is obtained for the co-
expression of EGFP-Cdc42N17 and mRFP-IRSp53, with a DK  >2 μM (Table 
7.1). This indicates there might be some weak interactions between EGFP-
Cdc42N17 and mRFP-IRSp53.  
 
Fig. 7.3 (D) shows the DK  plot of the positive control EGFP-mRFP. As we 
discussed in section 7.1.1, the photobleaching of fluorophores resulted in SW-
FCCS observing a mixture of “interacting complexes” EGFP-mRFP (both 
fluorescent) and “un-bound free particles” EGFP-mRFP*/EGFP*-mRFP 
(mRFP* and EGFP* is nonfluorescent). This construct could still be a positive 
control for DK  plot supposing the fraction of EGFP-mRFP* (denoted as gf ) 
and the fraction of EGFP*-mRFP (denoted as rf ) in the total EGFP-mRFP  
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molecules (denoted as EGFP mRFPc − ) are constant in sample cells.   
(1 ) (1 )
G R
g EGFP mRFP r EGFP mRFP g r
D EGFP mRFPGR
g r EGFP mRFP g r
f c f c f fc cK c
f f c f fc
− −
−
−
× ××= = =− − − −             (7.1) 
D EGFP mRFPK c −∝                                                                                             (7.2)  
DK  is proportional to the total concentration of EGFP-mRFP molecules that 
are expressed in the sample cell. Hillesheim et al. studied the photobleaching 
of EGFP and mRFP by using PCH (177). They reported that mRFP is more 
sensitive to photobleaching compared to EGFP, and the photobleaching rate 
is constant under the same experimental condition. Considering the 10% 
photobleaching of EGFP and ~70% of mRFP are dark (177), and assuming 
the total concentration of EGFP-mRFP is 1μM, a DK  value of 350 nM can be 
calculated from Eq. (7.1), which is similar to the plot value (~400 nM) in Fig. 
7.3 (D). For the negative control, no linear regression is obtained since there 
is no specific interaction between EGFP-Cdc42V12 and mRFP (Fig. 7.3 G). 
Therefore, from the DK  plot it is possible to tell whether there is interaction or 
no interaction between two FP-fusion proteins.  
 
Table 7.1 summarizes the DK  values from SW-FCCS measurements on the 
co-expression pairs of Cdc42 and its effectors. The two CRIB-containing 
effectors, mRFP-NWASP and mRFP-IRSp53, exhibited relatively small DK  
values for the binding of Cdc42V12 (27 nM and 391 nM). In contrast, the non-
CRIB-containing effector, mRFP-Toca1, showed a larger DK  value (1295 nM). 
The co-expression of EGFP-Cdc42N17/ mRFP-IRSp53 exhibited a larger DK  
value compared to the EGFP-Cdc42V12/ mRFP-IRSp53 pair (2186 nM vs. 391  
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Table 7.1 DK  values of different co-expression pairs of Cdc42 and its effectors 
 
Co-expression pair 
 
DK ±SE  
(nM)  
 
2R
 
n 
 
DK *    method
(nM) 
 
EGFP-Cdc42V12/ mRFP-NWASP 27±3 0.44 20 1a         SPA 
EGFP-Cdc42V12/ mRFP-IRSp53 391±33 0.83 18 20b       SPA 
EGFP-Cdc42V12/ mRFP-Toca1 1295±128 0.53 34 110c      SPA 
EGFP-Cdc42N17/ mRFP-IRSp53               2186±494 0.09 22 270d      FRET 
*: dissociation constants determined in vitro (cited from literature (193, 194)). 
a: binding of Cdc42L61 to WASP. 
b: binding of Cdc42L61 to Pak. 
c: binding of RacL61 to EGFP-Pak-EBFP (75-118). 
d: binding of RacL61 to EGFP-Pak-EBFP (75-118), DK  determined by FRET. 
 
nM), together with a small coefficient of determination ( 2R <0.1). This indicates 
that the interaction between dominant negative Cdc42 and its effector is much 
weaker or there might be no interactions, which is similar to the report by Cool 
et al. (195). Table 7.1 (right column) lists a series of DK  values from literature 
for the binding kinetics of constitutive active small GTPases and effectors that 
were determined in vitro. The first two DK  values (1 nM and 20 nM) are 
measured from Cdc42L61 binding to WASP and Pak, respectively (193). The 
following two values are the DK  of a constitutively active Rac mutant Q61L 
binding to the CRIB domain of Pak (residues 75-118) measured by either SPA 
(scintillation proximity assay) or FRET (194). The DK  value determined by 
FRET is larger than the one determined by SPA (270 nm vs. 110nm).  
 
Compared to the values determined by in vitro assays, the DK  values 
determined by SW-FCCS in vivo are larger. This could be attributed to several 
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factors. First, endogenous Cdc42 or effectors may compete in the interactions 
between FP-fusion Cdc42 and fusion effectors. CHO cells express 
endogenous hamster Cdc42 (196)  as well as IRSp53 (197-200). The 
concentrations of the endogenous proteins in CHO cells have not been 
determined and the actual concentration may vary from cell to cell. Fig. 7.4 C 
shows the simulation of the competition effect of non-labeled endogenous 
proteins on DK  values. The interactions of FP-fusion Cdc42 or fusion 
effectors with non-labeled endogenous proteins result in higher 
concentrations of apparent “un-bound” fusion Cdc42 or fusion effectors 
( *GC represents the apparent concentration of EGFP-fusion proteins and *RC  
represents the apparent concentration of mRFP-fusion proteins). The purple 
line is plotted by simulating a situation in which 50% of EGFP-fusion proteins 
interact with endogenous proteins, so that the actual concentration of EGFP-
fusion proteins GC  that interact with mRFP-fusion proteins is *0.5 GC . The 
actual DK  between EGFP- and mRFP-fusion proteins is assumed as 100 nM. 
Under the assumption that 50% of EGFP-fusion proteins interacting with 
endogenous proteins and the other 50% interacting with mRFP-fusion 
proteins, the apparent *DK  plotted from SW-FCCS analysis will be 200 nM. 
This shows that DK  shifts to larger values if endogenous proteins compete in 
the interactions between EGFP- and mRFP-fusion proteins. Fig. 7.3 shows 
that at higher concentrations a better regression is obtained. This indicates 
that the FP-fusion proteins need to be expressed at high concentrations to 
overcome the competition effects of the endogenous proteins. Second, 
photostability of the FPs may also affect the DK  values. For instance, if mRFP 
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is bleached in the binding complex EGFP-Cdc42V12/ mRFP-IRSp53, then the 
complex will be recognized as a free EGFP-Cdc42V12 as mRFP*-IRSp53 is 
not detectable. Consequently, the apparent concentration of “un-bound” 
EGFP-Cdc42V12 is larger than the actual concentration of free EGFP-Cdc42V12, 
and the apparent concentration of the binding complex becomes smaller than 
the actual concentration of binding complexes. As a result, the apparent DK  
determined will be larger than the actual DK . Alternatively, in vitro assays 
avoid the competition effects of endogenous proteins and photobleaching 
problem if unstable FPs are not employed in the assays, so that the DK  
values determined are smaller than the values from in vivo assays by SW-
FCCS. Besides, the data analysis for the DK  plot is based on a simple model, 
i.e. one Cdc42 molecule binds to one effector molecule and forms a 1:1 
complex. In live cell system the interactions may be more complicated. For 
example, some of the interacting partners could be in oligomeric forms, or 
several or more different molecules participate in the reaction and form a 
multi-component complex.  
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Fig. 7.4 Simulations of DK  plot under different conditions. (A) Relative 
expression levels of the two interacting proteins affect the point distributions 
on the regression line, but do not affect the slope of the line ( DK  value is 
constant for binding between green particle G  and red particle R ). (B) The 
regression lines shift toward Y axis with the increase of DK . (C) Non-labeled 
competitors result in the apparent concentrations *Gc of “un-bound” G and the 
apparent concentrations *Rc of “un-bound” R become larger than the actual 
concentrations Gc and Rc  in the equilibrium of the binding/dissociation 
reaction, so that the regression line shifts toward Y axis, i.e. the apparent *DK  
value obtained is larger than the actual DK . 
 
 
7.2    Competition effect on the dimerization of IRSp53 
IRSp53 is a multifunctional adaptor protein with an IMD domain (residues 1-
250), a partial CRIB motif (residues 268-280) and a SH3 domain (residues 
375-438) (200, 201). The IMD domain is a self-association domain. Crystal 
structure of the IMD domain reveals that it self-associates into a zeppelin-
shaped dimer (202). The chemical cross-linking experiments by Yamagishi et 
al. suggest that the full-length IRSp53 can be present as dimeric forms in 
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mammalian cells (203). Thus we set out to exam whether IRSp53 forms 
dimeric structures in live cells using the SW-FCCS setup. EGFP-IRSp53 and 
mRFP-IRSp53 plasmids (1 μg: 1 μg) were introduced in CHO cells by using 
Fugene 6 transfection reagent. For comparison, triple transfection with the 
addition of a third non-labeled IRSp53 (HA-IRSp53, HA is the hemagglutinin 
epitope tag) was also done under the same experimental condition. The 
plasmid ratio was kept at 1 μg EGFP-IRSp53: 1 μg mRFP-IRSp53: 1 μg HA-
IRSp53. Fig. 7.5 shows the SW-FCCS results on dimerization of IRSp53. A 
positive CCF is obtained from cells co-expressing EGFP-IRSp53/mRFP-
IRSp53 (Fig. 7.5 A), which indicates IRSp53 may exist in dimeric forms in the 
cell. Compared to (A), the CCF in Fig. 7.5 (B) is relatively lower than the two 
ACFs, which indicates the third non-labeled HA-IRSp53 competes in the 
dimer formation between the FP-fusion proteins.      
 
 
Fig. 7.5 Auto- and cross-correlation curves measured from CHO cells 
expressing (A) EGFP-IRSp53/mRFP-IRSp53 and (B) EGFP-IRSp53/mRFP-
IRSp53/HA-IRSp53. Autocorrelation curves of EGFP (green) and mRFP (red), 
and cross-correlation curves (blue) between the two are shown with their fits 
(solid curves). The CCF in (A) is relatively more approaching the ACFs 
compared to the CCF in (B), which indicates a decrease of cross-correlation 
possibly due to the competition effect of the non-labeled HA-IRSp53. 
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To further quantify the dimer formation of IRSp53, FCCS data were analyzed 
using the same theoretical model as that for the analysis of the dimerization of 
ErbB receptors (Chapter 5.3). Table 7.2 lists the dimer percentage of the 
EGFP-IRSp53/mRFP-IRSp53 determined by SW-FCCS measurements. The 
data from SW-FCCS measurements on cells expressing the EGFP-
IRSp53/mRFP-IRSp53/HA-IRSp53 and the cytoplasmic positive control 
EGFP-mRFP were analyzed through the same way for comparison. The 
dimer fraction dropped from 31% to 22% after adding the third unlabeled HA-
IRSp53 to compete in the dimer formation between EGFP-IRSp53 and 
mRFP-IRSp53. This indicates that IRSp53 forms dimers inside the cell, and 
SW-FCCS is applicable to detect dimer formation of cytoplasmic proteins as 
well as membrane receptors. 
 
Table 7.2 Competition effect of unlabeled IRSp53 on the dimer fraction of FP-
fusion IRSp53 in live cells 
 
Construct 
 
   Dimer %
   (± SD) 
 
Dimer % 
(± SE) 
 
 
Sample size
( n ) 
 
 
EGFP-IRSp53/mRFP-IRSp53 
(1 μg: 1μg)* 31 ± 24 31 ± 4 34 
EGFP-IRSp53/mRFP-IRSp53/HA-IRSp53
(1 μg: 1 μg: 1 μg)* 22 ± 18 22 ± 3 34 
EGFP-mRFP  
(cytoplasmic positive control) 38 ± 18 38 ± 4  18 
*: the mass amount of plasmids used in transfection.  
 
 
The cytoplasmic positive control EGFP-mRFP gives a smaller dimer 
percentage than that of the membrane positive control mRFP-EGFR-EGFP 
(38% vs. 70%) (Chapter 5.3). This could possibly be due to the fast 
 128
photobleaching rate of mRFP in the cytoplasm as we discussed in section 
7.1.1. In contrast, mRFP in the membrane located positive control mRFP-
EGFR-EGFP is more stable, as no fast photobleaching of mRFP was 
observed. The difference in photostability of mRFP in EGFP-mRFP and 
mRFP-EGFR-EGFP may be caused by the different subcellular locations of 
the two fusion proteins. mRFP in mRFP-EGFR-EGFP is located at the 
extracellular domain of EGFR, and the environment is PBS buffer (cells were 
covered by PBS during measurements). In contrast, mRFP in EGFP-mRFP 
locates in the cytoplasm of the cell, and the environment is re more complex 
as the surroundings are various kinds of molecules. Laser illumination causes 
conformational changes or photochemical reactions of the mRFP fluorophore 
so that it turns into dark states and the surrounding molecules may stabilize 
the conformational changes or reactions. Similarly, the dimer fraction of 
IRSp53 is also smaller than that of the ErbB receptors (31% vs. ~50%). 
Photobleaching or quenching of the FPs could be one reason. IRSp53 is a 
multifunctional adaptor protein and it distributes at different subcellular 
locations for multiple tasks (200, 201, 204-206), so that at different subcellular 
environments the interactions between IRSp53 and other molecules may 
affect the stability of the fluorophores. On the other hand, the interactions of 
IRSp53 with other biomolecules may induce or dissociate the dimeric form of 
IRSp53. For example, the IMD of IRSp53 dimerizes and crosslinks F-actin for 
actin-bundling and filopodium formation (202, 203). The dimeric RCB/IMD 
domain of IRSp53 induces membrane deformation in a Rac-dependent 
manner (201). Furthermore, Cdc42 binds to the CRIB motif of IRSp53 and 
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recruits the IRSp53-Eps8 complex to sites along leading edges, where the 
activated crosslinkers contribute to the actin bundle formation (205).   
 
7.3    Discussion 
In this chapter SW-FCCS was performed to study the interactions between 
the intracellular small GTPase Cdc42 and its effectors. For each EGFP- and 
mRFP-fusion pair, the relative expression levels of the two interacting 
partners may vary in a large scale as the two FPs are fused to different types 
of proteins. In contrast, the expression levels of EGFP- and mRFP-fusion 
ErbB receptors are more on the same scale as the two FPs are fused to the 
same receptor protein. If the expression level of EGFP-fusion proteins differs 
largely from that of mRFP-fusion proteins, the complex percentage calculated 
by Eq. (2.24) and Eq. (2.25) is not sufficient to distinguish the different 
interactions between Cdc42 and its effectors. Hence, in this chapter we 
focused on plotting the equilibrium dissociation constant DK  for each co-
expression pair of fusion Cdc42 and effectors.  
 
The DK  plot indicates whether there is interaction or no interaction between 
different proteins. All the co-expression pairs of active Cdc42V12 and effectors 
exhibited a linear regression line with 2 0.4R > , indicating there are 
interactions between Cdc42V12 and the effectors. Otherwise, there is no 
relationship between G Rc c×  and GRc  as shown by the negative control. This 
indicates that through plotting DK  it is possible to determine the interactions 
between different molecules by SW-FCCS. In addition, the two CRIB-
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containing effectors showed small DK  values (<0.4 μM) while the non-CRIB-
containing molecule exhibited relatively larger DK  value (>1 μM). This 
suggests that SW-FCCS may be applied to distinguish the binding strength 
between different interacting partners. However, in life cells this application is 
limited by the endogenous proteins that compete in the interactions between 
the fusion proteins. As a result, the DK  values determined in live cells by SW-
FCCS are generally larger than those determined by in vitro assays.  
 
In the second section SW-FCCS was performed to investigate the 
dimerization of IRSp53 in the cytoplasm of cells. The result shows that a 
certain percentage of IRSp53 forms dimeric structures. Hence, there is a 
possibility that Cdc42 may interact with the dimeric form of IRSp53. If one 
Cdc42 molecule binds to one IRSp53 dimer, the model used for plotting DK  is 
still applicable as the IRSp53 dimer can be assumed as one molecule. The 
only difference is that the brightness of IRSp53 dimer can double that of the 
monomer, but this should not affect much in the calculation as the actual cps 
of IRSp53 obtained from calibration was used in the calculation. On the other 
hand, if two Cdc42 molecules bind to one IRSp53 dimer, or the binding of 
Cdc42 induces dissociation of the IRSp53 dimer, the situation will be more 
complicated and the mathematical model needs to be modified. Alternatively, 
Cdc42 may also interact with one IRSp53 molecule in a complex with other 
proteins. Cdc42 has been reported to induce IRSp53:Mena complex formation 
(62) and Cdc42 binds to the Eps8-IRSp53 complex (205). Therefore, the 
interactions may involve more than two molecules. Dual-color SW-FCCS 
measurements indicate interactions between two FP-fusion molecules. For 
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the study of higher-order interactions, i.e. interactions among complexes 
formed by more than two molecules, multi-color SW-FCCS is one potential 
technique (74, 75).     
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Chapter 8 
Conclusion and Outlook 
 
The motivation for this work was the quantitative determination of 
biomolecular interactions in vivo by developing biophysical fluorescence 
techniques. The fundamental theory and in vitro experimental assays of SW-
FCCS were accomplished by Hwang and Wohland. In this thesis, dual-color 
SW-FCCS was further developed to monitor protein-protein interactions in live 
cells. The optical setup, choosing of FP tags and quantitative analysis of the 
experimental data were realized for SW-FCCS application in live cell system. 
In all, this thesis reveals SW-FCCS as a versatile biophysical technique to 
investigate biomolecular interactions in live cells.  
 
8.1 Conclusion 
The advances of modern microscopy techniques together with the fast 
development of novel fluorescent probes have provided a challenging 
opportunity to investigate complex processes in living biological systems. The 
work in this thesis presented the optical setup and application of SW-FCCS to 
study biomolecular interactions in live cells. Fluorescent proteins were chosen 
as the probes for labeling the target proteins, due to the advantages that FPs 
can be genetically tagged to target proteins with minimum perturbation on the 
study system. The combination of EGFP/mRFP has been shown to be a 
suitable FP pair for SW-FCCS at the excitation wavelength of 514 nm. 
Compared to the signals of EGFP/mRFP excited at 488 nm or EYFP/mRFP 
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excited at 514 nm, EGFP/mRFP excited at 514 nm give comparable signals in 
the two detection channels and minimum crosstalk between the two channels. 
The same SW-FCCS setup (including excitation laser line/dichroic 
mirror/emitter) was employed to measure different co-expression pairs of 
EGFP- and mRFP-fusion proteins in live cells.  The results of two positive 
controls (membrane mRFP-EGFR-EGFP and cytoplasmic EGFP-mRFP) and 
two negative controls (co-expression of membrane PMT-EGFP and PMT-
mRFP and co-expression of cytoplasmic EGFP and mRFP) prove that the 
optical setup is applicable for the study of subcellular interactions by SW-
FCCS using EGFP/mRFP pair. 
   
This thesis focused on the study of the interactions between signaling proteins. 
Two groups of signaling proteins have been investigated, the membrane ErbB 
receptors and the intracellular small GTPase Cdc42 and its effectors. 
Interactions between ErbB receptors are essential for the receptors to process 
signal transduction. One major controversy in the activation mechanisms of 
ErbB receptors is whether the receptors exist in monomeric or dimeric forms 
prior to ligand binding. In this thesis SW-FCCS was performed to detect 
cross-correlation between FP-fusion ErbB receptors. Quantitative analysis on 
the SW-FCCS results show that the dimer percentages of EGFR/EGFR, 
ErbB2/ErbB2 and EGFR/ErbB2 are much higher than that of the negative 
controls and approaching that of the positive control. This indicates that the 
majority of the ErbB receptors perform dimeric structures on cell surface 
before ligand stimulation. The triple transfection of EGFP-EGFR/mRFP-
EGFR/pNUT-EGFR experiment showed that with the increase of untagged wt 
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EGFR plasmid, the average dimer (EGFP-EGFR/mRFP-EGFR) percentage 
decreased. This experiment indicates that the third untagged wt EGFR 
competes in the dimer formation between EGFP-EGFR and mRFP-EGFR, 
and further confirmed the dimer percentages obtained for the co-expression 
pairs of ErbB receptors. 
 
FCS observations on FP-fusion EGFRs showed slower diffusion and irregular 
high-intensity fluorescence peaks in seconds after EGF activation, indicating 
the mobility of the receptors is slowed down upon ligand binding, and the 
receptors form aggregates or higher-order oligomers after activation. SW-
FCCS experiments were also carried out to observe the receptors’ behavior 
during EGF stimulation, and endocytosis inhibitors were applied to keep the 
activated receptors staying on the membrane for a relative stable observation 
on the surface receptors. At the first few minutes the CCF was similar to that 
before adding EGF, indicating that EGF does not induce more dimer 
formation, i.e. the dimers are preformed before ligand binding. After a few 
more minutes, irregular high-intensity peaks with different intensity values 
were observed, indicating that the activated receptors cluster into 
microdomains or form different high-order oligomers. In conclusion, SW-
FCCS measurements indicate that the ErbB receptors preform dimeric 
structures before ligand binding, and the activated receptors form aggregates 
or high-order oliogmers as observed by FCS/SW-FCCS.  
 
SW-FCCS was further applied to study the interactions between intracellular 
signaling proteins, i.e. Cdc42 and its effectors. The equilibrium dissociation 
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constants DK  for each co-expression pair of FP-fusion Cdc42
V12 and its 
effectors was plotted, indicating the interactions between Cdc42V12 and the 
effector proteins. The DK  values for the CRIB-containing effectors are 
different from the non-CRIB-containing effector, which suggests that SW-
FCCS may be applied to distinguish the binding strength between different 
interacting partners. However, the DK  values obtained from in vivo SW-FCCS 
measurements are limited by the endogenous proteins that compete in the 
interactions between target proteins. As a result, the in vivo DK  values from 
SW-FCCS are larger than those obtained from in vitro assays. Besides, SW-
FCCS measurements on co-expression of EGFP-IRSp53/mRFP-IRSp53 and 
triple transfection of EGFP-IRSp53/mRFP-IRSp53/HA-IRSp53 reveal that 
IRSp53 can form dimeric structures in the cytoplasm of the cell. This 
experiment shows that SW-FCCS is feasible to detect the dimer formation not 
only between membrane proteins but also between cytoplasmic proteins.  
 
To summarize, this thesis reveals the primary advantage of SW-FCCS, i.e. to 
quantitatively determine protein-protein interactions in live cells. EGFP/mRFP 
pair is suitable for SW-FCCS at excitation wavelength of 514 nm, as revealed 
by the positive and negative controls both on membrane and in the cytoplasm 
of the cell. The interactions between target proteins can be presented by 
either dimer (complex) percentages or DK  plot. In fact, SW-FCCS verifies the 
concentrations of the different forms of target proteins, i.e. un-bound form and 
bound (complex) form. The mathematical model can be modified into all kinds 
of possible forms according to the interacting/reaction system. Consequently, 
SW-FCCS is a versatile quantitative technique in the study of biomolecular 
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interactions in vivo. Limitations of this technique and possible solutions will be 
given in the subsequent section. 
 
8.2 Outlook 
The study of biomolecular interactions is of fundamental importance for us to 
understand processes and events in biological systems. This thesis reveals 
SW-FCCS as a novel biophysical fluorescence technique for in vivo study of 
biomolecular interactions. However, several factors may affect the in vivo 
application of SW-FCCS. These factors include (1) photostability of the 
fluorophores; (2) competition effects of endogenous proteins; (3) 
multicomponent (>2 molecules) involved in the interactions. Accordingly, this 
outlook will focus on three main directions, i.e. developments of new 
fluorescent probes, possible modifications of biological systems, and 
modifications and combinations of optical systems.     
 
To develop new fluorescent probes with high quantum yield and long-term 
photostability is critical in improving the detection efficiency of SW-FCCS. 
Fluorescent probes include various organic dyes and the fast enlarging 
fluorescent protein family. Especially, FPs play crucial roles in visualization 
and tracking subcellular compartments and events in vivo since FPs can be 
genetically encoded with targets of interest. In recent years, a variety of 
fluorescent proteins/variants with improved properties have been developed in 
academic research laboratories as well as in biological companies (109, 166). 
This provides an opportunity to choose and combine novel FPs for the 
application of SW-FCCS. Note except for brightness and photostability, SW-
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FCCS also requires the excitation wavelengths of the FPs to be close as a 
single laser line is used to excite the two FPs. To minimize crosstalk, the 
emission spectra of the FPs need to be well-separated. This in turn requires 
the development of FPs with long Stokes shift. Kogure et al. developed a FP 
variant with a large Stokes shift which can be combined with CFP for SW-
FCCS application (165). However, the brightness and photostability of CFP is 
not as good as other common FPs (166). In this thesis EGFP/mRFP has been 
shown to be a useful combination for SW-FCCS at 514 nm excitation. The 
signals of the two FPs are comparable and the emission spectra of the two 
are well-separated. Still, this pair encounters the problem of the insufficient 
photostability of mRFP. Alternatively, mCherry could be a replacement for 
mRFP as it exhibits similar spectra to that of mRFP but superior photostability 
(166, 207). Note that red fluorescent proteins tend to oligomerize, and 
monomeric red fluorescent protein mutant should be chosen for SW-FCCS 
application to avoid the artifact of interactions between FPs. Hence, the 
development of monomeric fluorescent proteins with high sensitivity, large 
Stokes shift and good photostability will be ideal for in vivo application of SW-
FCCS.  
 
On the other hand, to develop organic dyes with large Stokes shift may also 
be adopted in the application of in vivo SW-FCCS. Organic dyes can be 
modified with functional groups that react with biomolecules, so that 
fluorophores are attached to target molecules. FPs can be genetically tagged 
to target proteins with superior advantages compared to organic dyes (109). 
However, if molecules of interest are not proteins but other cellular 
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components such as membrane lipids and secondary messenger molecules, 
it is more convenient to label these molecules with organic dyes than to label 
with FPs. MegaStokes dyes are commercially available organic dyes with 
large Stokes shift (208). The dyes can be modified with several functional 
groups, and hence could be applied to label different kinds of molecules. For 
example, MegaStokes dye-labeled lipid analogues can be incubated with cells 
expressing FP-fusion membrane proteins, so that SW-FCCS can be applied 
to study the protein-lipid interactions in vivo. Besides, other fluorescent probes 
such as quantum dots could also be used in labeling molecules in live cells 
(209).    
 
In the study of protein-protein interactions in vivo by SW-FCCS, endogenous 
protein may compete in the interactions between FP-fusion proteins and affect 
the quantitative analysis. Several possible solutions may be taken into 
consideration. First, choose a cell line that does not endogenously express 
target proteins. In this thesis CHO cells were chosen for the study of 
interactions between ErbB receptors, as CHO cells do not express 
endogenous EGFR and only express background level of ErbB2. However, 
the situation for the intracellular Cdc42 is much more complicated. Cells may 
not only endogenously express target proteins but also express other proteins 
that interact with either Cdc42 or the effector proteins. One possible solution 
is to express much higher concentrations of FP-fusion target proteins 
compared to the concentrations of endogenous proteins, so that the 
competition effect of endogenous proteins could be negligible. On the other 
hand, gene knockout can be applied to block the expression of competitive 
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endogenous proteins in the selected cell line. Besides, small RNA 
interference may also be applied to suppress some competing protein gene 
expression, so as to alleviate the competition effect.   
 
Biomolecular interactions often involve more than two components. Several 
promising techniques can be developed for the in vivo study of multi-
component interactions. First, with the development of FPs or dyes with 
separate spectra, it is possible to label multicomponents and study their 
interactions by multi-color SW-FCCS. The in vitro multi-color SW-FCCS to 
detect higher order molecular interactions has been demonstrated  (74, 75), 
which has paved the way for in vivo application of multi-color SW-FCCS. 
Second, in the situation of the same protein forming oligomers in the 
interacting complex, combining SW-FCCS with PCH (or FIDA) technique 
could be one practical solution. FCCS and PCH can use the same optical 
setup, and the difference between the two is in the data processing procedure. 
Therefore, by combining the two techniques SW-FCCS results and PCH 
results can be obtained for the same interacting complex. SW-FCCS results 
indicate the interaction between different FP-fusion or dye-labeled molecules 
in the complex, and PCH results provide the information of oligomer formation 
by the same molecule in the complex. On the other hand, the development of 
high sensitivity charge-coupled devices (CCD) offers an opportunity to 
combine SW-FCCS with multi-color fluorescence imaging or TIRF. The fast-
rate CCD camera captures multi-color images and auto- and cross-correlation 
can be performed either online or offline (210). FCS/SW-FCCS provide the 
information about the mobility and interactions of target molecules, and the 
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high quality images by CCD camera provide the spatial information such as 
the cellular distribution of target molecules. In all, the combination of SW-
FCCS with imaging techniques opens an exciting area to visualize, track and 
quantify biomolecules and events with high spatial and temporal resolutions in 
vivo.  
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